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POPULAR SCIENCE SUMMARY OF THE THESIS 
Wound dehiscence and Incisional hernia are anticipated complications to abdominal 
surgery. Wound dehiscence is when the sutures in the abdominal wall separate, bursting the 
wound under the skin. Wound dehiscence is always a severe condition, especially in elderly 
and critically ill patients. Wound dehiscence can cause injury to intestines, as well as 
infection and organ failure. In cases where the sutures in the skin also fail, abdominal 
content can poke out through the skin. This is called burst abdomen. Normally patients that 
are affected by wound dehiscence need renewed surgery where the abdomen is resutured. 
Sometimes, because of swelling of the abdominal organs and infection, it is not possible to 
close the abdomen when wound dehiscence has occurred. In these cases, the abdomen must 
be left open and the patient will require repeated operations and intensive care before 
getting well. Wound dehiscence patients have a higher postoperative mortality rate than 
surgery patients in general, and there is also a high risk for incisional hernia after wound 
dehiscence.  
Incisional hernia on the other hand develops when the wound has healed, but due to 
impaired healing of the abdominal tendon small bits of the peritoneum bulge under the skin, 
sometimes containing intra-abdominal fat. An incisional hernia can be very disabling, 
causing pain and local symptoms. In unlucky cases a sling of the small bowel can be caught 
in the incisional hernia. This is called incarceration and is a potentially life-threatening 
condition. Symptomatic incisional hernias normally need surgery. After an operation for 
incisional hernia patients may suffer from stiffness and pain from the abdominal wall. 
Yearly about 1800 incisional hernia surgeries are performed in Sweden according to the 
Swedish ventral hernia registry. A reduction of incisional hernias would save considerable 
health care resources and reduce suffering.  
In recent years the methods to close the abdominal wall have developed, and studies show 
that a meticulous suturing technique for closing the abdominal wall can reduce the above-
mentioned complications significantly. The new technique uses a suture that is slowly 
absorbed by the body. With this technique stitches in the abdominal tendon are made small 
and placed close together. The wound and the length of the suture is measured, and a quota 
is calculated to ensure that the right technique has been used.    
Even after the new suturing technique has been introduced 5-10% of patients still develop 
an incisional hernia and a few percent a wound dehiscence. To further reduce these 
numbers, high risk patients must be identified, and special precautions made to protect 
them.    
Many hospitals use the new technique for closing the abdominal wall, but far from all do. 
The department of Surgery at Capio S:t Görans hospital introduced the technique as early 
as 2012 in a structured quality effort, and the technique is integrated in standard practice 
and used by all abdominal surgeons.  
The aim of this thesis has been to follow up on the structured implementation of the new 
surgical technique to see the long-term results. 
By looking at large Swedish patient registries, this thesis has intended to identify risk 
factors for wound dehiscence and incisional hernia in the population.  
Furthermore, to test a new technique to reinforce the abdominal closure to avoid wound 
dehiscence and incisional hernia.    
Paper 1 – A retrospective study of the implementation of the new surgical technique at 
Capio S:t Görans hospital. 
The study investigates the long-term impact of the change in technique by examining data 
on patients operated on before the implementation of the technique in 2012 and some years 
after the implementation. 
93% of patients in the post implementation group had their abdomen closed according to 
the new technique, and the suturing technique was also correctly noted in the medical 
records. This compared to only 1% in the pre-implementation group. Incisional hernia and 
wound dehiscence proved to be at the same levels both before and after the implementation 
of the new technique, about 4-5%, which is normally considered an acceptable level. High 
BMI and postoperative wound infection proved to be risk factors for incisional hernia 
development. Male gender, high age, chronic obstructive pulmonary disease and wound 
infection were risk factors for wound dehiscence development.     
Four years after the implementation, the new technique was fully integrated as standard 
practice at S:t Görans Hospital. The reason that there was no difference in complications 
between the groups is most likely due to that a sufficient surgical technique was already in 
use before the structured implementation.   
Paper 2 – A study of the Swedish colorectal cancer registry to find the incidence of 
incisional hernia in the Swedish population. 
This paper studies the incidence of incisional hernia in the Swedish population and looks 
for relevant risk factors by building a database combining the Swedish colorectal cancer 
registry and the Swedish national patient registry. The risk for developing an incisional 
hernia in the population was 5,3% for the population as a whole. Male gender, long surgery 
duration, age less than 70 years old, high BMI and wound infection were risk factors for 
incisional hernia development.  
Paper 3 - A study of the Swedish colorectal cancer registry to find the incidence of wound 
dehiscence in the Swedish population. 
By looking at the same database as paper 2, the incidence of wound dehiscence and 
relevant risk factors can be explored. A significantly higher risk for postoperative death is 
recorded for wound dehiscence patients.  High age, male gender, high BMI, chronic 
obstructive pulmonary disease, systemic inflammatory disease, and a short surgery duration 
were risk factors for wound dehiscence in the study.  
Paper 4 – Pilot study to test a new surgical devise.  
In this study we tested a new technique where the abdominal wall, after suturing, is 
reinforced with a surgical net. The net that was tested is made from a synthetic material that 
is absorbed by the body in about 6 months. In this pilot study we found that the technique 





Wound dehiscence and incisional hernia are dangerous and resource consuming 
complications to abdominal surgery.   
High age, high BMI, long operation time, chronic obstructive pulmonary disease, and 
systematic inflammatory disease are risk factors for complication after abdominal surgery. 
There is also an increased risk for men.    
Postoperative wound infection is a strong risk factor for further wound complications, and 
all possible actions should be undertaken to avoid wound infection.   
A structured implementation when introducing a new surgical technique works well and 
has a long-lasting effect.  
Implantation of TIGR® Matrix surgical mesh is a possible way to reinforce the abdominal 





Stor bukkirurgi innebär dessvärre att komplikationer kan uppstå. Sårruptur och ärrbråck är två 
fruktade sådana komplikationer. En sårruptur innebär att suturerna i bukväggen släppt och att 
såret under huden spricker upp. En sårruptur är alltid ett allvarligt tillstånd, framför allt hos 
äldre, och kan leda till tarmskador, infektioner och organsvikt. Det kan också vara associerat 
med att hudsuturerna spricker upp, vilket i sin tur kan få till följd att bukinnehållet glider ut ur 
buken. Vanligen behöver patienter som drabbas av sårruptur en omoperation där buken sys 
ihop igen. Det händer att man pga. svullna tarmar och inflammation inte kan stänga buken 
efter en sårruptur. Då behöver buken lämnas öppen och det krävs intensivvård och upprepade 
operationer innan patienten är färdigbehandlad. Efter en operation av sårruptur är risken att 
senare utveckla ärrbråck mycket hög. 
Till skillnad från sårrupturer innebär ärrbråck att operationssåret har läkt, men på grund av en 
defekt läkning av bukväggssenan buktar en mindre eller större snip av bukhinna och 
bukinnehåll fram under huden. Ett ärrbråck kan vara mycket invalidiserande och ge uttalade 
lokala besvär. I olyckliga fall kan en tarmslynga glida ut i ärrbråcket och klämmas fast. Detta 
kallas inklämning och är ett potentiellt livshotande tillstånd. Om patienten har uttalade besvär 
så behöver detta opereras. En operation av ärrbråck kan ge smärtor och stelhet i bukväggen. 
Årligen utförs c:a 1800 sådana operationer enligt svenska bukväggsbråckregistret. En 
minskning av antalet ärrbråck skulle spara stora sjukvårdsresurser och minskat lidande.  
De senaste tio åren har metoden att försluta buken efter operation utvecklats och studier har 
visat att komplikationer enligt ovan kan minskas med en strukturerad och noggrann 
bukförslutningsteknik. Tekniken går ut på att man använder en tråd som långsamt löses upp 
av kroppen efter c:a sex månader och att man syr med små täta tag i bukväggssenan. Sedan 
mäter trådåtgång och sårets längd och räknar ut en kvot för att kontrollera att rätt teknik har 
använts.   
Även med modern sutureringsteknik drabbas c:a 5-10% av patienterna av ärrbråck och några 
procent av sårruptur. För att ytterligare minska dessa risker behöver högriskpatienter kunna 
identifieras och ytterligare åtgärder vidtas för att skydda dessa.  
Många sjukhus, inte bara i Svergie, använder idag en strukturerad teknik för 
bukförslutningen, men långt ifrån alla gör det. Kirurgkliniken vid Capio S:t Görans sjukhus 
introducerade tidigt den nya tekniken och började redan 2012 att försluta buken enligt ett 
standardiserat vetenskapsbaserat protokoll som sedan dess följs av alla klinikens kirurger.  
Syftet med detta avhandlingsarbete har varit att följa upp hur införandet av en standardiserad 




Genom att använda de stora svenska patientregistren identifiera riskfaktorer för ärrbråck och 
sårruptur i den svenska befolkningen.  
Testa en ny teknik för att förstärka bukförslutningen så att inte sårruptur och ärrbråck uppstår.   
Arbete 1 – En återblick på införandet av den strukturerade bukförslutningstekniken vid Capio 
S:t Görans sjukhus 
Vi undersökte vad bytet till den moderna strukturerade bukförslutningstekniken hade för 
effekt på lång sikt. Genom att samla in data på patienter opererade innan införandet 2012 och 
data frånpatienter som opererats fyra år efter införandet samlade vi totalt 1120 patienter. Vi 
fann att 93% av patienterna i den sena gruppen hade fått buken försluten med en korrekt 
teknik, vilket också noterats korrekt i journalen, att jämföras med 1% före införandet.  
Ärrbråck och sårruptur visade sig vara lika vanligt före som efter införandet av den nya 
tekniken, c: a 4–5%, vilket anses vara en acceptabel nivå. Högt BMI och postoperativ 
sårinfektion visade sig vara riskfaktorer för att utveckla ärrbråck. Manligt kön, hög ålder, 
kronisk obstruktiv lungsjukdom samt sårinfektion var riskfaktorer för sårruptur.    
Fyra år efter införandet var den nya tekniken helt integrerad i vårt arbetssätt. Att skillnaden 
inte var så stor beror sannolikt på att de flesta kirurger använde en tillräckligt bra teknik redan 
före införandet av den strukturerade tekniken.  
Arbete 2 – Studie på det svenska Colorektalcancerregistret för att få en bild av ärrbråcks 
utbredning hos patienter opererade för Colorektalcancer.  
I den här studien tittade vi på förekomsten av ärrbråck och sökte efter riskfaktorer för 
ärrbråcksutveckling genom att bygga en databas där vi kombinerade data från det svenska 
Colorektalcancerregistret och Slutenvårdsregistret. Risken att utveckla ärrbråck I 
studiepopulationen var 5,3%.  Manligt kön, lång operationstid och ålder under 70 år, högt 
BMI och sårinfektion visade sig vara signifikanta riskfaktorer för ärrbråcksutveckling  
Arbete 3 -– Studie på det svenska Colorektalcancerregistret för att få en bild av sårrupturers 
utbredning. 
Genom att titta i samma databas som i arbete 2 kunde vi utvärdera förekomsten av sårruptur 
efter Colorektalcancerkirurgi och dess riskfaktorer. Det var en signifikant ökad risk att dö i 
inom 30 dagar från operationen för de patienter som utvecklade sårruptur. Hög ålder, manligt 
kön, högt BMI, Kronisk obstruktiv lungsjukdom, systemisk inflammatorisk sjukdom och kort 
operationstid visade sig vara riskfaktorer.  
Arbete 4 – Pilotstudie för att testa nytt nätmaterial.  
I det här arbetet testade vi en ny teknik där man förstärker bukförslutningen med ett nät. Nätet 
som vi testade var av ett resorberbart material som tas upp av kroppen och med tiden 
försvinner. I den här pilotstudien fann vi att tekniken fungerade och att inga allvarliga 
komplikationer inträffade.  
 
Slutsatser 
Ärrbråck och sårruptur är farliga och kostsamma komplikationer till bukkirurgi.  
Hög ålder, högt BMI, lång operationstid, kronisk obstruktiv lungsjukdom, systemisk 
inflammatorisk sjukdom är riskfaktorer för komplikation efter öppen bukkirurgi. Det 
föreligger också en ökad risk för män.   
Infektion i operationssåret är en stark riskfaktor för ytterligare komplikationer och man bör 
vidta alla åtgärder för att undvika infektion.  
Strukturerat införande av en ny kirurgisk teknik fungerar och har en bestående effekt.  







Incisional hernia and Wound dehiscence are potentially serious complications to midline 
incisions. Recent studies have shown that a meticulous suturing technique can reduce the rate 
of these complications significantly, but even with optimal technique there is 5-15% risk of 
abdominal wall complications. At Capio S:t Görans hospital the new abdominal wall closure 
technique 2012 was implemented in a standardised quality improvement project.  
 
The aim of these studies was to investigate the effect of a structured implementation of the 
new surgical technique, to study which risk factors for incisional hernia and wound 
dehiscence are relevant in a Swedish population and to test new techniques to reinforce the 
abdominal wall after open abdominal surgery.  
 
Methods  
Study 1.  
All procedures performed via a midline incision 2010-2011 before, and 2016-2017 after the 
new protocol was introduced at Capio S:t Görans Hospital were identified and assessed for 
complications and risk factors for wound dehiscence and incisional hernias  
Study 2.  
All procedures registered in the Swedish Colorectal Cancer Register (SCRCR) 2007–2013 
were identified. Patients with comorbid disease diagnoses, registered at admissions and visits 
prior to the procedure and relevant to this study, were obtained from the National Patient 
Register (NPR). Data on occurrence of incisional hernias were obtained by combining data 
from the SCRCR and the NPR). 
Study 3.  
Like study 2 all open abdominal procedures for colorectal cancer registered in the SCRCR 
2007–2013 were identified. Potential risk factors for wound dehiscence were identified by 
cross-matching between the SCRCR and the NPR. The endpoint in this study was reoperation 
for wound dehiscence registered in either the SCRCR or NPR. 
Study 4  
Sixteen patients with three or more risk factors for wound dehiscence or incisional hernia 
were included. A TIGR® Matrix mesh was placed on the aponeurosis with an overlap of five 
cm on either side and fixated with continuous monofilament polydioxanone suture. All 
postoperative complications were registered at clinical follow-up. 
  
Results  
Study 1  
After the implementation of new guidelines, 93% of procedures were performed using the 
standardised technique for abdominal wall closure. There was no significant difference in 
incidence of incisional hernia or wound dehiscence between the two periods. BMI>25 and 
postoperative wound infection were found to be independent risk factors for incisional hernia. 
Male sex, high age, chronic obstructive pulmonary disease, and postoperative wound 
infection were risk factors for wound dehiscence. 
Study 2 
The cumulative incidence of incisional hernia in the population was 5.3%. In multivariate 
analysis male gender, operation time exceeding 180 min, body mass index (BMI) > 30, age < 




In multivariable analysis, age > 70 years, male gender, BMI 
> 30, chronic obstructive pulmonary disease, generalised inflammatory disease, and duration 
of surgery less than 180 min were significant risk factors for wound dehiscence. The hazard 
ratio for postoperative 
death was 1.24 for patients who underwent reoperation for wound dehiscence compared with 
that for controls. 
Study 4 
One patient developed a seroma that needed drainage and antibiotic treatment. One patient 
had a wound infection that needed antibiotic treatment. There was no complication requiring 





High age, high BMI, long operation time, chronic obstructive pulmonary disease, systemic 
inflammatory disease, and male gender should be considered risk factors for postoperative 
adverse events after a midline incision.  
Postoperative wound infection is a strong predictor of incisional hernia and wound 
dehiscence and all measures possible should be taken to avoid wound infection.   
Structured implementation of a standardised surgical technique is possible and has a long-
lasting effect.  
Implantation of TIGR® Matrix mesh is a feasible way to reinforce the abdominal wall after 
high-risk surgery.  
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In 2012 I became aware that the rate of wound dehiscence in our general surgery department 
was too high. I investigated the problem and found good evidence to suggest that we should 
implement a structured closure technique after midline incision of the abdominal wound, to 
reduce this complication. After discussions and education of the surgical staff, we 
implemented the Small-Stitch-Small-Bites technique (SSSB) in the summer of 2012 to 
improve the safety of abdominal wall closure. This had an immediate and dramatic impact on 
outcome. In the spring prior to implementation, twelve patients suffered a burst abdomen 
which needed acute reoperation and prolonged hospital stay. In the autumn that same year 
only one patient needed reoperation for a burst abdomen. I was amazed that such a simple 
intervention could have such an impact. In the years following implementation of SSSB the 
lower rate of wound dehiscence persisted with four-five cases per year. In my initial follow-
up, I found that wound dehiscence patients needed a long hospital stay and that our 
intervention saved us more than one bed per day all year round in our ward. Furthermore, 
resources were saved due to a reduction in incisional hernia surgery. This experience led me 
to further investigate the mechanisms of wound dehiscence and incisional hernia, and to see if 
it is possible to reduce the risks associated with midline incisions. This thesis is the result of 
these studies. 
 
The aim of this thesis has been to follow up on the structured implementation of the new 
surgical technique to see the long-term effect. 
Studying the incidence of incisional hernia and Wound dehiscence after a midline incision.  
Identifying risk factors for wound dehiscence and incisional hernia in the Swedish 
population.  





1.2 ANATOMY OF THE ABDOMINAL WALL 
(1–3) 
 
The abdominal wall is a complex construction of muscles, nerves, vessels, aponeuroses, and 
tendons bridging between the thorax and the pelvis. The functional purpose of the abdominal 
wall is to keep the trunk upright and support movement. The abdominal wall also protects the 
internal organs and keeps them in place. Defects in the abdominal wall can thus affect 
posture, impair mobility, and cause displacement of internal organs.  
The lateral abdominal wall has three flat muscles. The transversus abdominis, as its name 
suggests, runs transversely and is the innermost muscle. The main function of the transversus 
abdominis is to hold the internal organs in place during activity. The internal oblique muscle 
runs laterocaudally from the midline. The internal oblique takes part in breathing and can turn 
and tilt the upper body. The external oblique muscle runs laterocranially from the midline. 
The main function of the external oblique is rotation and flexion of the upper body. These 
three flat muscles form the core construction of the abdominal wall that supports movement 
and posture, and confines and protects the internal organs. The rectus abdominis muscles run 
in craniocaudal direction on either side of the midline. The aponeuroses of the three flat 
muscles form the rectus sheath within which the rectus abdominis muscle runs. The recti 
abdominis are the main flexors of the upper body. The rectus sheaths meet in the midline 
where they join to form the linea alba, also named the rectus aponeurosis. The blood supply 
to the abdominal wall comes from two systems. The epigastric arteries run in a craniocaudal 
direction parallel to the midline on both sides. The intercostal and subcostal arteries as well as 
the circumflex iliac arteries form branches that run between the transverse and the internal 
oblique muscles. The nerve supply to the abdominal wall muscles is derived from the lower 
intercostal nerves, the thoracoabdominal nerves and the iliohypogastric nerves. The rectus 
aponeurosis is a strong tendinous, avascular structure with little nerve supply. 
 





1.3 THE MIDLINE INCISION 
Throughout surgical history a variety of incisions have been used to access the abdominal 
organs, all having advantages and disadvantages (4). The midline incision is associated with 
low risk for damage to nerves or vessels (1,5). Furthermore, it does not require transection of 
muscles, which makes it fast and easy to perform (3,6,7). The level of the midline incision 
may be chosen depending on what procedure is intended, and it is easy to extend the incision 
if necessary. The midline incision provides good access to most abdominal organs and is 
suitable for acute surgery. A disadvantage of the midline incision is the relatively high risk 
for incisional hernia (6–11).  
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1.4 PRINCIPLES OF WOUND HEALING 
Wound healing after an incision can be divided into three phases (9,12,13). During the first 
acute inflammatory phase, vasodilatation leads to an invasion of leucocytes and 
macrophages. The main role of these cells is to remove dead cells and debris from the 
incision site and to protect the wound from bacterial invasion. The macrophages also attract 
fibroblasts, which are important in the early phase of regeneration (9,12,13). The extent of the 
acute inflammatory reaction ranges from 0.5 cm to 1.5 cm from the fascial edges, somewhat 
wider if wound infection is present (9,12,14,15). During the acute inflammatory phase, which 
lasts for about four days, the wound itself has no tensile strength. During this period the 
suture holds the entire tensile strength of the wound which explains why wound dehiscence 
most often occur during this phase (14,16,17). Infection during the acute inflammatory phase 
increases the number of leukocytes but not macrophages. This prolongs the acute 
inflammatory phase, but the decline in macrophages decreases the number of fibroblasts 
attracted (12). There is evidence that the use of diathermy, especially in the coagulation 
mode, can affect the blood supply of the fascial edges and inhibit wound healing (18). 
The second, regenerative phase, is characterised by collagen formation mediated by invading 
fibroblasts (9,12). Disturbances in collagen metabolism is believed to play a major role in the 
formation of incisional hernia (12,17,19–22). There are over twenty collagen types, all with 
individual characteristics. Collagen type I gives strength to the scar whereas the role of 
collagen type III is primarily to form a matrix. Collagen type III is produced in the early 
remodeling phase. The weaker collagen type III is then remodeled to collagen type I. The 
collagen type I/III ratio is used as a measure of collagen quality (19,21). A lower collagen 
I/III ratio is seen in incisional hernia patients than in controls (19,22). The collagen I/III ratio 
can be measured in skin, fascia, or in rectus aponeurosis tissue itself to identify patients with 
a high risk for incisional hernia (19,21,22). Another way to identify patients at risk is to 
measure the turnover of different types of collagen. Reduced turnover of collagen type V 
(Matrix) and increased turnover of collagen type IV (strength) is seen in patients who develop 
an incisional hernia. (23) Matrix metalloproteinases (MMP) break down extracellular matrix 
and may serve as markers of collagen turnover. Levels of certain MMPs are believed to 
predict hernia formation (17,19,21). MMP-2 activity is increased in obese patients, resulting 
in an increased breakdown of type I collagen during the regenerative phase. This leads to a 
reduced type I/type III collagen ratio, and thus the synthesis of mechanically weaker tissue 
(24). Abdominal aortic aneurysm is significantly associated with hernia formation and shares 
many risk factors. MMP-2, MMP-9 and MMP-13 activities are associated with both hernia 
and aneurysm disease, indicating that both could be symptoms of a systematic connective 
tissue disease (22,25,26). 
The regenerative phase lasts for approximately three weeks. At the end of the regenerative 
phase the wound has achieved 15-20% of the original tissue’s strength (2,9,12). 
The third remodeling phase lasts up to one year. During this phase, mechanical tension of the 
wound stimulates collagen remodeling leading to more organized and stronger structures. By 
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the end of this phase, the rectus aponeurosis has regained 60-90% of its original strength 
(9,12,13).  
1.5 INCISIONAL HERNIA 
Incisional hernia is defined as any abdominal wall gap with or without a bulge in the area of a 
postoperative scar perceptible or palpable by clinical examination or imaging (27). Simply 
put, an incisional hernia is a defect in the abdominal wall covered by neoperitoneum, formed 
at the site of a previous surgical incision. Sometimes the hernia is just a defect, and 
sometimes a lump is formed under the scar. The hernia sac can contain abdominal fat or 
organs and in unfavourable cases this can lead to incarceration and strangulation of the hernia 
sac contents. The rate of incisional hernia after open abdominal surgery varies in the 
literature. It is normally reported to be up to 20% (28,29), but in more recent studies it has 
been shown to be as low as 5-13% with meticulous suturing technique (30,31). An incisional 
hernia can present years after index surgery (32–34). The late diagnosis of incisional hernia 
can partly be due to authors using different definitions of incisional hernia. With the 
definition above, about 90% of hernias can be detected within a year after index surgery (6). 
In most cases, incisional hernias can be diagnosed by thorough clinical examination, but 
complementation with computed tomography can be helpful in obese patients (32,35). In a 
study by Ah-Kee et al, one third of patients were not aware they had an incisional hernia, and 
one third had noticed the defect but were asymptomatic (29). Typical symptoms of incisional 
hernia include pain, discomfort, functional disability, and cosmetic disturbance (29,36). The 
natural course of incisional hernia is not known, nor the probability of an asymptomatic 
patient developing symptoms. Reports in the literature state that only 1% of hernia patients 
suffer incarceration (36). In a systematic review by Bosanquet et al 2015 (37), the overall 
cumulative incidence of incisional hernia was 12%. Forty-nine per cent of patients with an 
incisional hernia were symptomatic and 36% underwent surgery.  Incisional hernia is costly 
(38,39) and prevention of may thus be considered a very cost-effective measure (39,40). In 
the USA, the number of operations for incisional hernia and the cost of each operation 
increased each year between 2007 and 2011. One of the reasons for this is that we tend to 




1.6 ABDOMINAL WOUND DEHISCENCE 
Wound dehiscence is defined as separation of the abdominal fascia after surgery (9) .  There 
are four principal mechanisms of wound dehiscence: suture rupture, knot failure, slack suture 
(because of large bites including fatty tissue), or sutures cutting through the fascia; the last-
named being the most common (14,42–44). Early wound dehiscence can be dramatic with 
protrusion of abdominal organs through the wound; also known as burst abdomen. More 
frequently, however, wound dehiscence is a subclinical condition that is seen as a precursor 
of incisional hernia (16,45,46). Of patients that have a radiologically diagnosed wound 
dehiscence at an early stage, 92% later develop an incisional hernia (46). Wound dehiscence 
usually occurs during the first 3-7 days (47–50) but diagnosis is often delayed. Burst 
abdomen is rare, with an incidence of approximately two per cent of elective abdominal 
surgery patients. In acute or emergency cases, the reported incidence of burst abdomen is as 
high as 12-50% (9,51,52). At clinical examination, early wound dehiscence presents with 
secretion from the wound, that is often misinterpreted as an infection. More severe cases can 
be easily diagnosed with CT-scan where dehiscence in the fascia is seen with abdominal 
organs close to the skin. Depending on the size of the fascial defect, there is a risk for 
ischaemia of protruding organs (9). Burst abdomen is a very serious condition with high 
morbidity and a reported mortality of 25% or higher (48,52–56), and hospital stay is 
significantly longer (44). In the case of a large fascial dehiscence, emergency surgery is 
needed. There are no large RCTs on the various treatment options for burst abdomen, and the 
evidence level is weak. If possible, an attempt is made to close the wound. However, due to 
intra-abdominal swelling, deep infection, or poor fascia quality, the wound is sometimes left 
open for a while before closure. Patients that are primarily sutured for burst abdomen have a 
very high incidence of incisional hernia (52,53,56–58). Closure and reconstruction with a 
mesh may provide a safer outcome and should be considered in these patients (52,59,60). The 
placement of a mesh does not seem to increase formation of enterocutaneous fistulae, (59) 
and seems safe even in a contaminated environment. For patients where primary closure is 
not possible, the recommendation is to use a dynamic closure technique where the fascial 
edges are kept under traction over a period until it is possible to close the wound. There are 
several different systems for dynamic wound closure, some of which can be used in 
combination with negative pressure wound therapy (NPWT) (60,61). A promising new 
concept for dynamic wound closure, where a combination of mesh augmentation and NPWT 
is used, has been described by Petersson et al (62). Patients that are operated for burst 









1.7 RISK FACTORS FOR WOUND DEHISCENCE AND INCISIONAL HERNIA.  
Many studies have been performed to identify risk factors for incisional hernia and wound 
dehiscence (55,63–65) but only a few have been performed after new guidelines for closing 
the abdominal wall were published in 2014 (4,49). Most studies do not describe the surgical 
technique used to close the aponeurosis and thus neglect one of the most important risk 
factors (2). All the risk factors presented here were reported in studies performed before the 
closure paradigm shift, and may be considered irrelevant since studies performed after the 
2014 guidelines fail to show any significant risk factors (66). When Millburn et al first 
reported the excellent outcome of the SSSB technique, they found no significant risk factors. 
In a retrospective study by Aksamija et al on over 3000 patients operated 2013-2016, 44 
(1,25%) cases of clinically significant wound dehiscence were found; too few to find 
significant risk factors (49).   
In 2018, Wiegering et al presented an interesting retrospective control-matched cohort study 
(67) where they could exactly specify which surgical technique had been used. The same 
technique was used in all patients (continuous monofilament, with a suture length /wound 
length ratio of over 4:1). In that study, no significant risk factors for incisional hernia could 
be found, and they failed to show that abdominal aortic aneurysm surgery patients have a 
higher risk than colon cancer patients for incisional hernia. This confirms the findings of 
Israelsson et al (68,69), that with a good suturing technique the disease behind surgery has 
little importance for the development or not of incisional hernia.  
With meticulous suturing technique, prospective randomized trials predict a cumulative 
incidence of incisional hernia around 6-10% and burst abdomen approximately 1%. With 
such small incidences, large multicentre studies are required to further assess the underlying 
risk factors.  
Wound dehiscence and incisional hernia represent two different conditions with the same 
pathogenesis (46), both having their origin in the early separation of the fascial edges. Table 1 
shows known risk factors for incisional hernia and wound dehiscence and the studies that 
support them. Although surgical technique is the most important risk factor (31,66), we still 
need to be aware of the other risk factors. The presence of five or more of these risk factors 
has been suggested as a cut-off for high risk (65). 
One systematic review by Bosanquet et al 2015, including data from 14 618 patients, found 
that age, previous midline incision, previous hernia, AAA-surgery, surgery for obesity, and 
upper abdominal surgery were all risk factors (37). 
Several attempts have been made to design a risk score for incisional hernia and wound 
dehiscence.  
Ramshorst et al, in a large retrospective case-control study including patients between 1985 
and 2005, assessed risk factors for wound dehiscence and developed a risk score model (64). 
Their aim was interesting, but the risk score they developed is limited by the fact that it 
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includes two strong postoperative risk factors, wound infection and postoperative coughing. 
These two risk factors have an overwhelming influence on the risk for abdominal wall 
complications but are impossible to use as targets for prevention, making the model 
unsuitable to identify patients that require pre- or perioperative prophylactic measures.  
Goodenough et al, in a study based on open vs laparoscopic surgery taking into account a 
variety of methods for closing the abdominal aponeurosis, prospectively assessed risk factors 
for incisional hernia and suggested a risk score (70). They found that apart from open 
surgery, obesity and COPD were significant risk factors.  
The most recent risk calculator comes from the University of Pennsylvania. In a retrospective 
study, Basta et al collected information from over 29 000 patients from large databases and 
developed a risk score based on preoperatively known risk factors for incisional hernia (71). 
The material for this study was wide and included gynaecologic and urologic surgery, as well 
as open and laparoscopic approaches. The overall rate of incisional hernia in the study was 
3.8%. Risk factors included colorectal surgery, history of previous abdominal surgery, and 
smoking. No information on the method used for closing the abdominal wall was given. The 
risk predictor is easily available as a smartphone app or online (72). 
These risk models are useful tools for preoperative workup to identify patients at high risk for 
incisional hernia. As yet, no risk model exists that assumes use of the small-stitch-small-bites 
surgical technique, and there is a need for more studies to identify risk factors that remain 
relevant using this modern surgical technique.  
Itatsu et al, 2014, published a large well-designed study including over 4000 patients (73). 
They concluded that high BMI, thick subcutaneous fat, age, chemotherapy, female sex, and 
blood transfusion were independent risk factors. Although the authors state that a continuous 
slowly absorbable monofilament suture should be standard for closure, only 443 of the 4000 
patients had the aponeurosis closed with this technique. In the risk analysis, there was an 
increased risk for incisional hernia when using interrupted sutures, but this was not 
significant.    
Wound infection is a very strong risk factor for both incisional hernia and wound dehiscence 
(64,65,69,74,75). Wound infection is a postoperative outcome with its own risk factors 
(76,77). To lower the rate of incisional hernia and wound dehiscence risk factors for wound 
infection can be assessed preoperatively in the risk score. One theory is that some cases 
reported as a wound infection might, in fact, be early wound dehiscence. This theory has yet 
to be confirmed, although Millbourn et al concluded that compared to closure with small 
stitches, the use of large stitches doubled the risk for wound infection and that is an 
independent risk factor (77). This suggests that wound infection in some cases is caused by 




Obesity (BMI>30) (65,70,73,75,77–81) and male gender (64,75,77,82) are frequently 
reported risk factors for incisional hernia and wound dehiscence. In a retrospective study, 
Aquina et al found that visceral obesity, not high BMI per se, should be regarded as a risk 
factor for incisional hernia (83). Visceral obesity is easily approximated by measuring the 
perirenal fat surface area (PRF). Studies confirm that a high PRF predisposes to postoperative 
complications (84–86). Another suggested measurement is the Hip-Waist Ratio which has 
been shown to be a better predictor of complications after surgery than BMI (87). Male sex 
predisposes to visceral obesity (88), and this possibly explains some of the gender difference.  
One underlying factor associated with obesity and postoperative complications is insulin 
resistance (IR). Insulin resistance is common after major surgery, even in non-diabetic 
patients (89), and animal studies show that IR leads to impaired wound healing after surgery 
(90). Obesity has a strong association with IR and about 40% of obese patients can be 
expected to be insulin resistant (91,92). This association is also evident for visceral obesity 
(93). Perioperative IR can be prevented by carbohydrate loading (94), and because of its 
association with postoperative complications, IR is targeted and treated in the enhanced 
recovery after surgery (ERAS) programme (95).  
The role of connective tissue quality in the development of incisional hernia is a topic of great 
interest. As explained in the section on hernia formation, the turnover of collagen type V 
(matrix) is reduced, and the turnover of collagen type IV (strength) is elevated in hernia 
patients. Biomarkers of collagen type IV turnover are altered in hernia patients (17) as is the 
collagen I/III ratio (19).  Pogacnik et al, 2014, examined the risk for incisional hernia in colon 
cancer patients and diverticulitis patients undergoing sigmoid colectomy. They found an 
increased risk for incisional hernia in the diverticulitis group. This suggests that diverticulitis 
patients have impaired connective tissue function that predisposes to their disease as well as 
to incisional hernia (78). Future studies on incisional hernia should recognize connective 
tissue quality and collagen metabolism as potential risk factors. Smoking is a strong 






1.7.1 Table 1 Reported risk factors for wound complication 
 
Significant risk factors  Ref nr 
High age  (37,55,64,65,69,73,81,82) 
Emergency surgery (55,64) 
Cancer (11,55,65,81) 
Haemodynamic instability  (55,65,73,78) 
Male gender  (64,75,77,82) 
Female gender  (73,88) 
Hypertension  (64,65) 
Chronic pulmonary disease (64,65,70,75,81) 
Ascites  (64,65) 
Anaemia (11,64,81) 
Jaundice  (64) 
Corticosteroid use (64,65,78,81,89) 
Sepsis (64,65,81) 
Postoperative coughing (63,64) 
Wound infection (63–65,68,69,74,75,77) 




Left colon or rectal cancer (88) 
Chemoterapy  (73,81,90) 
Previous hernia  (37,78,90,91) 
Thick subcutaneous fat (73) 
High ASA score (78) 
Abdominal aortic aneurysm repair (37,80) 







1.8 THE SMALL-STITCH-SMALL-BITES (SSSB) TECHNIQUE  
 
There has been a paradigm shift on midline incision closure over the past ten years based on 
the findings of the Sundsvall group (30,30,40,42,66,68,68,77,97,98). The Sundsvall results 
have also been reproduced in the STITCH trial (31). This method has become the 
recommended standard since 2014 (4,28,99) and has seen widespread use since 2010.  
The work that made way for the modern technique for abdominal wall closure began in 1976 
when Jenkins suggested that a running monofilament suture with a suture length to wound 
length ratio of at least 4:1 would prevent suture cutting through the tissue, thereby avoiding 
burst abdomen (100). In 1994, Israelsson et al showed that a slowly absorbable suture was as 
safe as nylon when closing the abdominal wall (101). Sahlin et al conducted a randomised 
controlled trial that failed to show that the continuous suture is superior to the interrupted 
technique, though the continuous suture was as good as the interrupted (102). In 1995, 
Niggebrugge et al showed that a running monofilament suture was superior to the interrupted 
technique to prevent incisional hernia (74). 
Jenkins ideas were taken up by Israelsson et al in1993 when they proved that a suture length 
to wound length ratio greater than 4:1 reduces the rate of incisional hernia (69). They also 
found that the 4:1 method reduced midline incision complications (68,103), and that the 
technique was cost effective (39).  
In animal studies, Cengiz et al 2001 showed that only including the aponeurosis in the sutures 
instead of mass layer suture leads to less fascial separation (98), and that small tissue bites 
with a suture length /wound length ratio of at least 4:1 gives higher bursting strength than 
large bites (97). This was confirmed by Harlaar et al in 2009 showing that small stitch length 
and small distance between the stitches gives the suture line better tensile strength than large 
stitches (104). Millbourn et al, 2004, re-evaluated old data from the Sundsvall group, 
concluding that short stitch length (small bites) is preferable. (30) 
In a randomised controlled trial Millbourn et al tested the SSSB method. They showed that 
closing the abdominal wall with a running suture and a suture length to wound length ratio of 
at least 4:1 with small bites involving only the aponeurosis is superior to large (at least 
10mm) bites in preventing wound dehiscence and incisional hernia (66,77). The rate of 
incisional hernia using the small bites method was 5,6% compared to 18% in the large bites 
group (77). In 2015, Deerenberg et al published their randomised controlled trial comparing 
small bites to large bites, where small bites gave an incisional hernia rate of 13% and large 




In 2014, the European Hernia Society recommended “a slowly absorbable monofilament 
suture in a single layer aponeurotic closure technique without separate closure of the 
peritoneum, and that the small bites technique with a suture to wound length (SL/WL) ratio at 
least 4/1” (4) should be used to prevent wound dehiscence and incisional hernia formation.  
Recording suture length to wound length ratio in the surgical report is a routine that does 
much to ensure that the appropriate technique is being applied (69,75). In 2014, Walming et 
al attempted to confirm this in a retrospective study (75) but they failed to do so, probably 
because a meticulous suturing technique was already standard even though the ratio was not 
noted in the report. This highlights the need for a universal way to describe the technique 











1.9 PROPHYLACTIC MESH AUGMENTATION 
Despite meticulous suturing technique, approximately 5-10% of patients develop an 
incisional hernia and 1% suffer burst abdomen. The use of prophylactic mesh augmentation 
has been suggested to prevent these adverse events (4,105). In a meta-analysis from 2013, 
Bhangu et al concluded that prophylactic mesh applied as onlay, inlay, or sublay, 
significantly reduces the risk for incisional hernia in high risk patients (105). 
In 2017, Borab et al concluded that prophylactic mesh dramatically reduces the risk for 
incisional hernia, but at the cost of more seroma formation and the possibility of chronic pain 
(106). Studies included in their review used both sublay and onlay placement. The increase in 
risk for seroma formation was mostly seen in the onlay mesh population. 
Caro-Tarrago et al, in a randomised controlled trial, found that onlay mesh reduces the rate of 
incisional hernia. They also pointed out that although onlay mesh leads to more seroma 
formation, all their patients could be managed conservatively (107). The onlay technique is 
easily learned and fast compared to the sublay technique (107). This makes onlay placed 
mesh a suitable prophylactic measure. 
At present there is no consensus as to which patients require mesh, what material should be 
used, and in which position the mesh should be placed (4). More studies on these issues are 
needed. 
1.10 PROPHYLACTIC RETENTION SUTURES 
Another technique to reduce the rates of incisional hernia and burst abdomen is to reinforce a 
tensioned suture line using retention sutures. Retention sutures are strong and are placed at 
wide intervals across the incision line deep within the musculature and fasciae of the 
abdominal wall. A skin protection device is often used, and the retention sutures are left for 
some days to lessen the tension on the midline incision during the initial healing phase. 
Retention sutures are easily removed by cutting the suture at the skin and then withdrawing 
them. In 2013, Khorgami et al suggested that retention sutures could prevent wound 
dehiscence in a high risk population (108). Modern closure techniques were not used in their 
study and they reported a 13% clinically significant wound dehiscence rate in the control 
group. The European Hernia Society reviewed the evidence for retention sutures and 
concluded that they should not be recommended in their guidelines (4). More studies are 




1.11 SWEDISH COLORECTAL CANCER REGISTRY AND THE NATIONAL 
PATIENT REGISTRY. 
The Swedish Colorectal Cancer Register (SCRCR) is a national quality register for colorectal 
cancer. The register has collected data from all patients diagnosed with rectal cancer in 
Sweden since 1995, and all patients with colon cancer since 2007. The Register includes data 
on age, gender, ASA classification, treatment, and postoperative follow-up, but lacks data on 
comorbidity and medical treatment. Completeness of the SCRCR is over 98% for both colon 
and rectal cancer, and validity data shows an average agreement of 90% (109–111). 
The Swedish National Patient Register (NPR) is supervised by the National Board of Health 
and Welfare. The register contains data on all hospital admissions in Sweden since 1987, 
including outpatient specialist care visits and outpatient emergency care. It does not, contain 
data on primary healthcare visits. The validity of the NPR is estimated to be 85–90% 
(112,113). 
 







1.12 IMPLEMENTATION OF A NEW TECHNIQUE 
At the Capio S:t Görans Hospital the Donabedians triade structured model is used for quality 
improvement. The triade states structure, process, and outcome as the three main pillars for 
improvement (114). The goal is to achieve organisational learning. In this case, we aimed to 
reduce the rate of complications after midline laparotomies by implementing new methods 
for opening and closure of the abdomen, especially the suturing technique. The structure 
included new suturing material, a new surgical routine, and documentation. Following 
theories originally developed by Argyris (115), we formed double learning loops aimed at 
organisational learning i.e., incorporation of knowledge and experience into the 
organisation’s structure such that these persist over time despite changes in personnel.  
Our work on wound dehiscence started with value stream mapping(116). For this we used the 
A3 tool (117) - an example of A3 (in Swedish) can be found in Appendix 1.  
After value stream mapping we concluded that too many patients developed wound 
dehiscence. Thus, we collected data from all laparotomies performed during a 6-month period 
and saw that compared to results in the literature we were doing poorly. After reviewing the 
literature on abdominal wall closure, we formed a multidisciplinary team including surgeons, 
a theatre nurse, a surgical assistant nurse, and an external product specialist from a suture 
company. The team developed a strategy for the implementation of a new suture technique 
using new material. The strategy included written guidelines for abdominal opening and 
closure (Appendix 2), including routines for documentation and follow-up. Before 
implementation several meetings were held with the surgeons and the surgical staff 
discussing the new routine. Lectures were given by Leif Israelsson, founder of the SSSB 
technique, and by the suture manufacturer. Feedback from these meetings was incorporated 
in the guidelines before launching the project. The original trial lasted six months during 
which time we closely monitored how things were going and were open to changes in 
routine. To maintain motivation, a small symbolic gift was given as a reward to those 
surgeons who kept to the guidelines. After six months we the entire staff had adapted to the 
new technique and it was found both feasible and effective. Since then, loop learning has 





2 PATIENTS AND METHODS 
2.1 PAPER 1. SMALL-STITCH-SMALL-BITES TECHNIQUE: A LONG-TERM 
FOLLOW-UP.  
Based on the evidence presented by Milbourn et al, (66,77), Capio S:t Görans Hospital 
implemented the SSSB technique as standard for midline incision closure. Prior to the new 
guidelines, abdominal wall closure was according to the preference of the surgeon, which 
was usually a running polydioxanone (PDS) 0 loop suture on a large needle. No record of 
layers included or suture length to wound length ratio was made in the surgical report. In the 
revised local guidelines June 2012, the full SSSB technique was described step by step using 
2-0 PDS suture on a small needle, taking small bites in aponeurosis only. It was also 
obligatory to measure and work out the suture length to wound length ratio and to record 
these in a separate document. To obtain a deep organisational learning of the new technique 
we used a double loop learning process (115). Before the implementation, all surgeons were 
educated in the new technique and got the chance to present their thoughts through local 
seminars where the technique was discussed. There were guest lectures by experts of the 
SSSB-technique, and organised self-studies. During the first six months the surgical 
technique used was monitored closely so that all surgeons cohered. (Delete – repetition!) 
This study was a retrospective review of all abdominal surgeries performed 2010-2011 and 
2016-2017 at the Department of Surgery, Capio Sankt Göran Hospital, Stockholm. Cases 
were identified by ICD10 codes JA-JX in the Cambio Cosmic medical records database 
(118). Laparoscopic cholecystectomy, laparoscopic appendectomy, anal/perianal surgery, and 
bariatric procedures were excluded. The remaining list was then cleared of all laparoscopic 
procedures and procedures not performed through a midline incision. In a last step, all cases 
not fitting the study design, for example where the abdomen was left open, were excluded. 
The final list was then reviewed by two examiners who scrutinised each patient’s records, 
starting at the index operation extracting data on potential patient-related risk factors and 
verifying that the procedure was performed through a midline incision. The surgery records 
were then reviewed to confirm if the study criteria were fulfilled i.e., SSSB with appropriate 
suture used and the suture length, wound length, and ratio Over 4:1 were correctly noted in 
the operation records. At the end of the study period, all patient records were reviewed to find 
postoperative complications or time of death. The endpoint “incisional hernia” was defined as 
either a clinically evident hernia noted on routine follow-up radiology or visit, incisional 
hernia accidently diagnosed clinically or by radiology at any other visit to the hospital where 
the abdomen was examined, or surgery for incisional hernia during the follow-up period. 
There was no standard protocol for follow-up for all laparotomies since patients were 




The follow-up of patients in this study included medical records and radiology reports from 
all contacts with the hospital until 31st March 2020. “Wound dehiscence” was defined as 
clinically evident fascial dehiscence noted and treated conservatively in the postoperative 
period, or an acute reoperation for wound dehiscence. End of follow-up for patients in the 
study was defined as the 31st March 2020, or date of death registered in Cambio Cosmic 
software, or 31st December the year the patient died in cases where the exact date of death 















2.2 PAPER 2.  
INCISIONAL HERNIA AFTER SURGERY FOR COLORECTAL CANCER: A 
POPULATION-BASED REGISTER STUDY. 
This was a population-based cohort study. All procedures for colorectal cancer registered in 
the Swedish Colorectal Cancer Register (SCRCR) 2007–2013 were identified. Diagnoses 
from all admissions and visits prior to colorectal cancer resection (identified by the 
International Classification of Diseases [ICD] code) were retrieved from the National Patient 
Register (NPR). We identified diagnoses that were generally considered to be risk factors in 
clinical practice, and collected general descriptive variables including: 
• Peripheral vascular disease 
• Connective tissue disorder  
• Liver cirrhosis 
• Renal failure 
• Diabetes 
• Chronic obstructive lung disease 
• Chronic inflammatory condition  
• Age 
• Body mass index (BMI) 
• Gender 
• Operation time 
• T-category 
• Distant metastases 
• Preoperative radiation therapy 
• Type of incision 
• Acute/planned surgery 
• Tumour localisation 
• Postoperative wound complication 




Cross-matching between the SCRCR and the NPR was performed in 2015 using the Swedish 
Personal Registration Number, a ten-digit identity number unique for each Swedish citizen 
(119).  
Data on incisional hernias were obtained by combining data from the SCRCR and the NPR. 
The endpoint incisional hernia was defined as incisional hernia registered in the SCRCR by 
the surgeon responsible, or ICD codes K43.0–K43.9 for incisional hernia or intervention 
codes JAD10–JAD87 for surgery for incisional hernia recorded in the NPR. Analyses were 
performed to assess the impact of each risk factor investigated and to estimate the cumulative 




2.3 PAPER 3.  
INCIDENCE OF WOUND DEHISCENCE AFTER COLORECTAL CANCER 
SURGERY: RESULTS FROM A NATIONAL POPULATION-BASED 
REGISTER FOR COLORECTAL CANCER. 
This study like Study 2 was based on data from the SCRCR combined with data from the 
NPR on colorectal cancer procedures performed 2007–2013. Patient data and potential risk 
factors included in the analyses were: 
• Peripheral vascular disease 
• Connective tissue disorder 
• Liver cirrhosis  
• Renal failure 
• Diabetes,  
• Chronic obstructive lung disease 
• Chronic inflammatory condition  
• Age 
• Body mass index (BMI) 
• Gender 
• Operation time 
• T-category 
• Distant metastases 
• Preoperative radiation therapy 
• Type of incision 
• Acute/planned surgery 
• Tumour localisation 
• Postoperative wound complication 




Cross-matching between the SCRCR and the NPR was performed in 2015 using Swedish 
Personal Registration Numbers.  
Data on wound dehiscence were obtained by cross-matching data from the SCRCR and the 
NPR. The endpoint, wound dehiscence, was defined as either wound dehiscence registered in 
the SCRCR by the surgeon responsible, or the procedure code for wound dehiscence surgery 
(JWA00) in the NPR. Analyses were performed to assess the impact of each risk factor 
investigated and the incidence of wound dehiscence. 
2.4 SUBGROUP ANALYSIS OF ACUTE SURGERY BASED ON DATA FROM 
THE SCRCR  
After publication of Papers 2 and 3, where acute and elective surgery were treated as one 
group, the question was raised whether patients undergoing emergency surgery should be 
analysed separately in view of the higher risk for complications associated with acute 
surgery. As a result, an acute surgery subgroup analysis was performed based on the same 




2.5 PAPER 4 
PROPHYLACTIC RESORBABLE SYNTHETIC MESH TO PREVENT 
WOUND DEHISCENCE AND INCISIONAL HERNIA IN HIGH HIGH-RISK 
LAPAROTOMY: A PILOT STUDY OF USING TIGR MATRIX MESH. 
 
The study was performed as a case series of patients from Uppsala University Hospital, the 
Uppsala Cancer Clinic, and Karolinska University Hospital, Huddinge, who underwent 
surgery through a midline incision. Inclusion criteria were the presence of at least three 
documented risk factors for incisional hernia or wound dehiscence. Risk factors investigated 
in this study were:  
 
• Reoperation 
• Age over 80 years 
• Generalised malignant decease (presence of distant metastases at the time of 
surgery) 
• COPD Grades III–IV according to the GOLD classification (FEV1 <50% of the 
expected) 
• Serum albumin level <20 g/l 
• Sepsis i.e., infection in combination with abnormal values of two or more of the 
following: body temperature, heart rate, respiratory rate, blood gases, and white 
blood cell count 
• BMI >35 
• haemoglobin <80 g/l 
• Diabetes with secondary complications (angiopathy, nephropathy, or 
neuropathy) and insulin treatment 
• Steroid treatment (with at least 1 mg betamethasone daily or equivalent) for 7 
days preoperatively 
• Smoking (at least 10 cigarettes a day for 1 year) 
• Chemotherapy (last administration within 2 weeks prior to surgery)  
• Irradiation of the abdominal wall. 
 
The abdominal wall incision was closed with continuous Polydioxanon Suture (PDS) with a 
suture length to incision length ratio of 4:1, using the SSSB technique. After suturing, a 
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TIGR® Matrix Surgical Mesh was placed in the onlay position over the rectal aponeurosis 
with an overlap of 5 cm on either side. The mesh was fixated with a continuous PDS 2-0 
suture on each side parallel to the midline incision followed by skin closure. All patients were 
followed up according to routine clinical practice at each unit, but always including a follow-
up visit 1 month after surgery. Endpoints in this study were wound dehiscence, wound 
infection, seroma, and persistent pain. 
TIGR® Matrix Surgical Mesh is composed of two different synthetic resorbable fibres 
having different degradation characteristics. The first fibre, constituting 40% of the matrix, is 
a copolymer of polyglycolide, polylactide, and polytrimethylene carbonate. The second fibre, 
making up 60% of the matrix, is a copolymer of polylactide and polytrimethylene carbonate. 
Both fibres are degraded by bulk hydrolysis, resulting in a decreasing tensile strength caused 
by loss of fibres. In vitro tests have shown that the first fibre (polyglycolide, polylactide, and 
polytrimethylene carbonate) loses its functional tensile strength after 2 weeks, and in vivo 
studies in the abdominal wall of sheep have shown that it is fully absorbed after 4 months 
(120). Corresponding figures for the second fibre (polylactide and polytrimethylene 
carbonate) are 9 months and approximately 36 months, respectively. As the first fibre is 
resorbed, elasticity increases, which improves collagen formation. The TIGR Matrix Surgical 
Mesh is a resorbable mesh implant, classified as a Class III device in accordance with the 




2.6 STATISTICAL METHODS 
All statistical calculations were performed using SPSS 22.0-26.0 (Chicago, IL). 
Logistic regression was used to study the relationship between predictors (that can be 
continuous or categorical) and a binary outcome such as incisional hernia. Logistic regression 
uses the odds of the outcome to fit a curve and calculates odds ratios.  
In our studies we used logistic regression to identify possible risk factors from a dataset of 
multiple variables.   
Survival analyses such as logistic regression can investigate predictors and their relationship 
to a binary outcome. In survival analysis the observation time is included in the analysis 
which improves the possibility to find survival differences. The Kaplan-Meier Estimator 
(Kaplan-Meier curve) is a visualisation of the survival function, commonly used in medical 
statistics to visually compare survival in different groups.  
Cox proportions hazard analysis (121) studies the relationship between predictors and the 
survival time related to a binary outcome. Cox regression calculates survival as a linear 
function of the individual predictors with results presented as hazard ratios (relative risk). 
Survival analysis and Cox regression is used in our studies to model the impact of potential 
risk factors on survival.  
 
2.6.1 Paper 1 
Risk factors for wound dehiscence were analysed in uni- and multivariable logistic regression 
analyses. Variables assumed to be risk factors at the beginning of the study were included in 
the multivariate analysis. Risk factors for incisional hernia were analysed in uni- and 
multivariable Cox proportional hazard analysis, adjustment was made for all covariates 
assumed to increase the risk for development of incisional hernia. Subgroup analyses were 
performed to investigate risk factors in each group. Potential risk factors were also analysed 
for the two groups combined. All analyses were performed using the intention-to-treat 




2.6.2 Paper 2 
The impact of each potential risk factor on the risk for incisional hernia was evaluated in a 
survival analysis, applying the date of the primary procedure as the time of entry into the 
cohort. Date of death or end of follow-up were defined as censored events. Age, body mass 
index (BMI), and comorbid disease as risk factors for incisional hernia were analysed using 
Cox proportional hazard analysis. Gender, age, BMI, history of chronic obstructive 
pulmonary disease, diabetes with secondary complications, chronic renal disease, liver 
cirrhosis, systemic inflammatory disease, tumour stage category, distant metastases, 
preoperative radiotherapy, acute/planned surgery, tumour localisation, operation time, 
postoperative wound complication, and adjuvant cytostatic treatment were included as 
covariates in the analysis. 
2.6.3 Paper 3 
The presumed risk factors age, BMI, comorbid disease, presence of distant metastases, and 
operation time were analysed using univariable and multivariable logistic regression analyses. 
Survival after reoperation for wound dehiscence was analysed with Cox proportional hazard 
analysis.  
 
2.6.4 Subgroup analysis of acute surgery based on data from the SCRCR  
Difference in outcome between acute and elective surgery was examined with cross-
tabulation and Pearson’s chi-squared test. Acute surgery as a risk factor for incisional hernia 
was examined using survival analysis and Cox regression. Wound dehiscence was explored 
with logistic regression. Risk factors for incisional hernia were examined in univariable and 
multivariable Cox regression analyses where all suspected risk factors were included. Uni- 




















2.7  ETHICAL CONSIDERATIONS 
2.7.1  Papers 1-3  
All three studies were based on retrospective data from registers and patient records. Our 
main ethical considerations were patient integrity and patient autonomy.  
In Sweden, there is a great acceptance for using patient registers in decision-making and 
healthcare allocation. Most patients agree to have their data stored in various registers, and 
these are used to improve the quality of healthcare. In large retrospective studies such as 
these, obtaining patient consent would be very time-consuming making them practically 
impossible. Patient data was anonymised, and the code keys were kept separate from the data 
sets. All data were stored within hospital walls according to safety regulations. The data sets 
were processed and presented so that no patient could be recognised.  
Paper 1. Approved by the Swedish Ethics Review Authority.  Diary number (2019-05787) 
Paper 2. Approved by the Regional ethics Review Board in Stockholm ref. (2014/1351-31/5). 
Paper 3. Approved by the Regional Ethics Review Board in Stockholm, ref. (2014/1351-
31/5). 
 
2.7.2 Paper 4 
 
In this study we evaluated a new medical device. The product itself had already been tested 
on humans and found to be safe, but this was a new application of the device.  
The aim of the study was to improve patient safety i.e., there was a potential benefit for 
treated patients assuming a decrease in risk for serious complications after surgery. There 
was, however, a minor risk of discomfort from the mesh augmentation. Our assumption was 
that patient benefit would outweigh any disadvantage. Informed consent was obtained to 
ensure patient autonomy.  
 





3.1 PAPER 1 
Altogether 1120 midline laparotomies were included in the study, 518 in the study cohort and 
and 602 in the control cohort. A flow chart of the study assembly is presented in Fig 1. Mean 
follow-up time was 32 and 73 months in the study and control groups, respectively. 
Emergency surgery was 60% in both groups.  In the study cohort, 481 (93%) had correct 
SSSB suturing and a satisfactory suture length to wound length ratio (>4) noted in the 
operation report compared to 7 (1%) in the control cohort. No significant differences in 
wound dehiscence rates and incisional hernia rates were seen between the two cohorts.  
A total of 51 patients developed wound dehiscence, 19 (3,7%) in the study group and 31 
(5,1%) in the control group. Of these, 44 required emergency reoperation, 17 in the study 
group and 27 in the control group. Nine patients (18%) with a documented wound dehiscence 
later developed an incisional hernia.  
Twenty-seven patients (5.2%) in the study group and 33 (5.5%) in the control group 
developed an incisional hernia. There was no significant difference between the groups. Fig 2 
shows the Kaplan- Meier curves for the cumulative incidence of incisional hernia for the two 
groups. Fig 3 shows a per protocol analysis where patients sutured with SSSB are compared 
to those closed with the surgeon’s method of choice. There was no signifficant difference 
between these groups. Of the patients with an incisional hernia, 14 in the study group and 21 
in the control group required surgery. Surgical site infection (SSI) requiring antibiotic 
treatment developed in 16 patients (3%) in the study group and 23 (4%) in the control group. 
This difference was not statistically significant.  
 
Table 2 shows background data and a comparison of the two study cohorts.  
In the subgroup multivariable analysis of the study cohort (2016-17), male gender (p=0,011) 
was a significant risk factor for wound dehiscence. BMI>25 (p=0,007) and wound dehiscence 
(p=0,003) were risk factors for incisional hernia. Acute surgery, high age, COPD, and 
previous midline incision did not show a significant association in this group.     
Tables 3 and 4 present the results of univariable and multivariable analyses of potential risk 
factors for incisional hernia and wound dehiscence in the two cohorts combined.  
Male gender (p=0.003) and COPD (p=0.022) were significant risk factors for wound 
dehiscence. History of previous midline incision (p=0.051) and postoperative surgical site 
infection (p=0.053) showed a tendency to predict wound dehiscence, though not significant at 














Cox regression identified BMI>25 (p=0.002), postoperative wound infection (p=0.001), and 
wound dehiscence (p<0.001) as independant risk factors for incisional hernia. Figures 4, 5 






Fig 2 Cumulative incidence of incisional hernia intention-to-treat 
 
 





Figure 4. Cumulative incidence of incisional hernia: different BMI categories 
      
 
 








Table 2 Background data   
 
Background data  2010-2011 2016-2017 Total 
Male 285 (47.3%) 
 235 
(45.4%) 520 (46.4%) 
Female 316 (52.5%) 283 (54.6%) 599 (53.5%) 
Data on sex missing 1 (0.2%) 0 (0%) 1 (0.1%) 
Age (Standard deviation) 70.4 (16.6) 68.3 (16.6) 69.4 (16.6) 
Index surgery 
   
Explorative laparotomy 102 (16.9%) 75 (14.4%) 177 (15.7%) 
Stomach and duodenal surgey 20 (3.3%) 16 (3.1%) 36 (3.2%) 
Liver and bile duct surgery 5 (0.8%) 0 (0%) 5 (0.4%) 
Splenectomy 4 (0.7%) 2 (0.4%) 6 (0.5%) 
Colon and small bowel surgery 387 (64.3%) 386 (74.5%) 773 (69%) 
Appendectomy 20 (3.3%) 17 (3.3%) 37 (3.3%) 
Rectal cancer surgery 52 (8.6%) 19 (3.6%) 71 (6.3%) 
Hernia surgery 3 (0.5%) 1 (0.2%) 4 (0.36%) 
other 9 (1.5%) 2 (0.4%) 11 (1.0%) 
Acute surgery 363 (60.3%) 306 (59.1%) 669 (59.7%) 
Elective surgery 239 (39.7%) 212 (40.9%) 451 (40.3%) 
BMI (standard deviation) 24.4 (5.0) 24.7 (5.4) 24.5 (5.3) 
ASA I 66 (14.1%) 53 (10.9%) 119 (12.4%) 
ASA II 189 (40.5%) 184 (37.8%) 376 (39.2%) 
ASA III 181 (38.8%) 205 (42.1%) 387 (40.4%) 
ASA IV  30 (6.4%) 44 (9.0%) 75 (7.8%) 
ASA V 1 (0.2%) 1 (0.2%) 2 (0.2%) 
Data on ASA missing 135 (22.4%) 31 (6.0%) 166 (14.8%) 
Cronic obstructive pulmonary disease 61 (10.2%) 51 (9.8%) 112 (10%) 
Diabetes mellitus 67 (11.1%) 59 (11.3%) 126 (11.2%) 
Haemoglobin, g/L (standard deviation) 130 (20) 129 (21) 130 (20) 
Albumin, g/L (standard deviation) 26.4 (8.3) 31.0 (7.2) 29.2 (7.9) 
C-Reactive Protein, mg/L (standard deviation) 90 (108) 91 (112) 89.9 (109.4) 
Previous midline incision 170 (28.4%) 135 (26.1%) 307 (27.4%) 
Standardised technique (SSSB) used 7 (1.2%) 481 (93.9%) 491 (44.0%) 















Odds ratio (95% 
confidence interval) p 
Odds ratio (95% 
Confidence interval) p 
Primary procedure 2016-
2017 (reference category 
2010-2011) 0.70 (0.39-1.26) 0.231 0.72 (0.40-1.31) 0.283 
Male (ref Women) 1.94 (1.08-3.47) 0.027 2.57 (1.39-4.76) 0.003 
Age≥70 yrs (ref Age<70 
yrs) 1.78 (0.97-3.26) 0.063 1.02 (0.99-1.03) 0.130 
Acute surgery (ref elective 
surgery) 1.21 (0.67-2.18) 0.526 1.30 (0.71-2.38) 0.399 
BMI ≥25 (ref BMI<25) 0.78 (0.44-1.37) 0.385 0,76 (0.43-1.36) 0.361 
COPD 2.36 (1.15-4.87) 0.020 2.40 (1.13-5.10) 0.022 
Previous midline incision 1.82 (1.02-3.26) 0.043 1.82 (0,999-3.32) 0.051 
Postoperative wound 
infection 2.56 (0.87-7.51) 0.087 2.98 (0.988-8.96) 0.053 
 














Hazard ratio (95% 
Confidence interval) 
p 
Primary surgery 2016-2017 
(ref 2010-2011) 
1.12 (0.66-1.89) 0.688 1.34 (0.78-2.29) 0.294 
Male (ref women) 1.46 (0.88-2.43) 0.148 1.24 (0.71-2.14) 0.440 
Age ≥70 yrs (ref age <70 
yrs) 
0.76 (0.46-1.28) 0.764 1.00 (0.99-1.02) 0.724 
Acute surgery (ref elective 
surgery) 
0.72 (0.43-1.19) 0.194 0.72 (0.43-1.21) 0.213 
BMI ≥25 (ref BMI<25) 2.34 (1.33-4.10) 0.003 5.45 (1.39-4.33) 0.002 
COPD 0.96 (3.38-2.39) 0.925 0.93 (0.36-2.38) 0.878 
Previous midline incision 1.55 (0.92-2.62) 0.114 1.52 (0.89-2.59) 0.130 
Postoperative wound 
infection 
3.68 (1.67-8.09) 0.001 3.86 (1.73-8.59) 0.001 




3.2 PAPER 2 
Between 2007 and 2013, 39 984 patients were registered in the SCRCR. After excluding 
laparoscopic procedures, procedures repeated on the same patient, procedures with 
concomitant liver resection, and procedures without laparotomy, 28 913 patients remained in 
the study. The study cohort assembly flow chart is shown in Figure 7. Baseline characteristics 
of the study population are shown in Table 5. In all, 1352 (cumulative incidence 4,7 %) 
patients were either diagnosed with an incisional hernia or underwent surgery for incisional 
hernia. In the multivariate analysis, risk for incisional hernia was increased in males, long 
operation time (exceeding 180 min), age < 70 years, BMI > 30 and postoperative wound 
complication. Table 6 shows the results of the uni- and multivariable analyses of risk factors. 
Figures 8-12 shows the Kaplan-Meier curves for the significant risk factors. History of 
comorbid disease, tumour stage, tumour localisation, preoperative radiotherapy, adjuvant 
chemotherapy, postoperative bleeding, and acute/elective surgery had no statistically 
significant impact.  
In an additional analysis performed after publication, wound dehiscence instead of 
postoperative wound complication was analysed as risk factor. Wound dehiscence was seen 
to be a statistically significant risk factor for incisional hernia, hazard ratio 3.04 [95%CI 2.95-
3.93] p<0.001. The Kaplan-Meier curve for wound dehiscence related to incisional hernia is 
































Patients registered in the Swedish  
Colorectal Cancer Register  
(N=39   984)   
N=33 821   
Data on resection missing (N= 6163)   
N=32 348   
Laparotomy without surgery  
(N=1473)   
N=31 603   
Treatment withou t laparotomy  
(TEM, local excision, appendectomy,  
other, N= 745) 
  
  
N= 29 219   
Laparoscopic resection (N=2   384)   
Study population  
(N=28   913)   
Concomitant liver resection (N=306)   
 
 39 
Table 5. Baseline characteristics, study 2 
Mean age, years (standard deviation) 71.1 (11.5) 
Gender  
   Men 14 986 (51.8%) 
   Women 13 927 (48.2%) 
T  
0 292 (1.0%) 
I 1585 (5.5%) 
II 4595 (15.9%) 
III 16920 (58.5%) 
IV 5333 (18.4%) 
TX/unknown 188 (0.6%) 
N  
0 15904 (55.0%) 
I 7152 (24.7%) 
II 5491 (19.0%) 
NX/unknown 366 (1.2%) 
M  
0 24 207 (83.7%) 
I 3606 (12.5%) 
MX/unknown 1200 (3.8%) 
Treatment  
   Resection of ascending colon (including ileocecal 
resection) 10666 (36.9%) 
   Resection of descending colon (including sigmoid colon) 8544 (29.6%) 
   Resection of rectum (anterior resection and 
abdominoperineal resection) 8271 (28.7%) 
   Other (including resection of transverse colon and total 
colectomy) 1432 (5.0%) 
 
Stomy  
   Temporary 4307 (15.0%) 





Table 6. Univariable and multivariable Cox proportional hazard analysis of risk 




hazard analysis  
Multivariable 
Cox proportional 
hazard analysis  
Variable N 






Gender      
   Women (ref) 13 927 (48.2%)     
   Men 14 986 (51.8%) 1.47 (1.29-1.67) <0.001 1.40 (1.21-1.62) <0.001 
Age      
   >70 years (ref) 16 205 (56.0%)     
   ≤70 years 12 704 (43.9%) 1.59 (1.37-1.82) <0.001 1.34 (1.16-1.56) <0.001 
   Data on age 
missing 4 (<0.1%)     
BMI      
   <30 20 769 (71.8%)     
   ≥30 4 036 (14.0%) 1.94 (1.65-2.22) <0.001 1.78 (1.51-2.09) <0.001 
   Data on BMI 
missing 4 108 (14.2%)     
Chronic Obstructive 
Pulmonary disease      
   No 27 600 (95.5%)     
   Yes 1 313 (4.5%) 1.29 (0.94-1.76) 0.112   
Diabetes with sec 
complications      
   No 28 011 (96.9%)     
   Yes 902 (3.1%) 0.74 (0.46-1.20) 0.225   
Chronic kidney 
disease      
   No 28 309 (97.9%)     
   Yes 604 (2.1%) 0.87 (0.48-1.58) 0.656   
Liver cirrhosis      
   No 28 841 (99.8%)     
   Yes 72 (0.2%) 2.67 (1.08-7.67) 0.035   
Systemic 
inflammatory 
disease      
   No 28 376 (98.1%)     
   Yes 537 (1.9%) 1.10 (0.66-1.83) 0.725   
Adjuvant chemo      
   No 23 206 (80.3%)     







hazard analysis  
Multivariable 
Cox proportional 
hazard analysis  
Variable N 






T      
   1 (ref) 1 585 (5.5%)     
0 292 (1.0%) 0.94 (0.45-1.98) 0.873   
2 4 595 (15.9%) 1.13 (0.83-1.54) 0.439   
3 16 920 (58.5%) 1.01 (0.76-1.34) 0.954   
4 5 333 (18.4%) 0.99 (0.71-1.40) 0.987   
   TX/unknown 188 (0.7%) 1.21 (0.48-3.03) 0.684   
Distant metastases      
   No (ref) 26 348 (91.1%)     
   Yes 2 565 (8.9%) 0.94 (0.70-1.27) 0.701   
Preoperative 
radiotherapy      
   No 22 988 (79.5%)     
   Yes 5 897 (20.4%) 1.35 (1.16-1.57) <.001   
 28 (0.1%)     
Acute/planned 
surgery      
   Planned 24 520 (84.8%)     
   Acute 4 386 (15.2%) 1.04 (0.85-1.28) 0.686   
   Data on 
acute/planned 
surgery 7 (<0.1%)     
Tumor localization      
    Colon 20 642 (71.4%)     
    Rectum 8 271 (28.6%) 1.43 (1.25-1.64) <0.001   
Operative time      
   <180 minutes 13 509 (46.7%)     
   ≥180 minutes 14 426 (49.9%) 1.50 (1.31-1.72) <0.001 1.25 (1.08-1.45) 0.003 
   Data on operative 
time missing 978 (3.4%)     
Postoperative 
wound complication      
   No 27 142 (93.9%)     
   Yes 1 771 (6.1%) 2.29 (1.88-2.79) <0.001 2.09 (1.70-2.58) <0.001 
Postoperative 
bleeding and/or 
transfusion      
   No 28 630 (99.0%)     




Figure 8 Cumulative incidence of incisional hernia: gender  
  
 






Figure 10 Cumulative incidence of incisional hernia: age  
  
 





Figure 12 Cumulative incidence of incisional hernia: wound complication  
  





3.3 PAPER 3 
Between 2007 and 2013, 39 984 patients were registered in the SCRCR. After excluding 
patients who had not undergone surgery, patients on whom data on the procedure were 
missing, laparoscopic procedures, appendectomies, transluminal endoscopic mucosectomies, 
and local excisions, 30 505 patients remained in the study group. The flowchart for the cohort 
assembly is shown in Figure 14. Baseline characteristics of the study population are shown in 
Table 7.  
The incidence of reoperation for wound dehiscence was 2.9%. In multivariable regression, 
age > 70 years, male gender, BMI > 30, history of chronic obstructive pulmonary disease, 
history of generalised inflammatory disease, and operation time less than 180 min were found 
to be independent risk factors for wound dehiscence. Results of the uni- and multivariable 
logistic regression analyses are presented in Table 8.  
The single strongest risk factor was male gender (odds ratio 3.00; 95% confidence interval 
2.52–3.57). Diabetes, chronic renal disease, liver cirrhosis, and distant metastases had no 
impact on the risk for wound dehiscence. In univariable Cox regression analysis, the hazard 
ratio for postoperative death was 1.24 (95% confidence interval 1.12–1.38, p < 0.001) for 
patients that needed reoperation for wound dehiscence. When adjusting for the risk factors 
found to have a significant association with wound dehiscence, the hazard ratio was 1.26 
(95% confidence interval 1.11–1.43, p < 0.001). Fig15 shows Kaplan-Meier curves for 








Table 7. Patient characteristics, Study 3 
 
Mean age, years (standard deviation) 71.1 (11.6) 
Gender  
   Male 15 820 (51.9%) 
   Female 14 685 (48.1%) 
BMI≥30 4160 (13.6%) 
Chronic obstructive pulmonary disease 1383 (4.5%) 
Complicated diabetes 952 (3.1%) 
Chronic kidney disease 632 (2.1%) 
Liver cirrhosis 78 (0.3%) 
Generalised inflammatory disease 558 (1.8%) 
Mean operation time, minutes (standard 
deviation) 207 (115) 
TNM classification*  
T  
0 297 (1.0%) 
I 1594 (5.2%) 
II 4623 (15.2%) 
III 17166 (56.3%) 
IV 5746 (18.8%) 
TX/unknown 1079 (3.5%) 
N  
0 16046 (52.6%) 
I 7302 (23.9%) 
II 5697 (19.0%) 
NX/unknown 1460 (4.8%) 
M  
0 24537(83.7%) 
I 4649 (12.5%) 
MX/unknown 1319 (4.3%) 






Table 8. Univariable and multivariable logistic regression analyses with wound 










Odds ratio (95% 
confidence 
interval) p 
Odds ratio (95% 
confidence 
interval) p 
Gender      
   Female (ref) 244/14685 (1.7%)     
   Male 649/15820 (4.1%) 2.53 (2.18-2.94) <0.001 3.00 (2.52-3.57) <0.001 
Age      
   ≤70 years 287/13420 (2.1%)     
   >70 years (ref) 606/17081 (3.5%) 1.68 (1.46-1.94) <0.001 1.72 (1.46-2.02) <0.001 
   Data on age 
missing 0/4 (0%)     
BMI      
   <30 543/21700 (2.5%)     
   ≥30 184/4160 (4.4%) 1.80 (1.52-2.14) <0.001 1.98 (1.66-2.36) <0.001 
   Data on BMI 
missing 166/4645 (3.6%)     
Chronic obstructive 
pulmonary disease      
   No 809/29122(2.8%)     
   Yes 84/1383 (6.1%) 2.26 (1.80-2.85) <0.001 1.98 (1.52-2.58) <0.001 
Complicated 
diabetes      
   No 863/29553 (2.9%)     
   Yes 30/952 (3.2%) 1.08 (0.75-1.57) 0.677   
Chronic renal disease      
   No 870/29873 (2.9%)     















Odds ratio (95% 
confidence 
interval) p 
Odds ratio (95% 
confidence 
interval) p 
Liver cirrhosis      
   No 890/30427 (2.9%)     
   Yes 3/78 (3.8%) 1.33 (0.42-4.22) 0.631   
Generalised 
inflammatory 
disease      
   No 861/29947 (2.9%)     
   Yes 32/558 (5.7%) 2.01 (1.43-3.00) <0.001 2.27 (1.49-3.45) <0.001 
      
Liver and/or lung 
metastases      
   Yes 85/3372 (2.5%)     
   No 808/27133 (3.0%) 0.84 (0.67-1.06) 0.138   
      
      
Operation time      
   ≥180 minutes 402/14754 (2.7%)     
   <180 minutes 455/14525 (3.1%) 1.16 (1.008-1.32) 0.039 1.36 (1.17-1.59) <0.001 
   Data on operation 






Figure 15. Overall survival of patients undergoing and those not undergoing 







3.4 SUBGROUP ANALYSIS OF ACUTE SURGERY BASED ON DATA FROM 
THE SCRCR  
In the Study 2 cohort, 4386 (15,2%) of 24 520 had acute primary surgery. The cumulative 
incidence of incisional hernia was 3.81% for acute surgery and 4.82% in the elective surgery 
group (p=0,04). In survival analysis, there was no significant difference between the groups 
(p=0.735). The Kaplan-Meier curve comparing acute and elective surgery is shown in Fig16. 
BMI>30 (p=0.02) and wound dehiscence (p=0.00) were significant risk factors for 
development of incisional hernia in the acute surgery group. The results of the uni- and 
multivariable Cox regression analyses are presented in Table 9. Figs 17 and 18 show the 
survival functions? for BMI and wound dehiscence related to incisional hernia.  
In the Study 3 cohort, 5027 patients (16,5%) of the 30 505 underwent acute surgery. The 
cumulative incidence of wound dehiscence was 4.0% following acute surgery and 2.8% 
following elective surgery (p<0.01). In a logistic regression analysis, acute surgery was seen 
to be a significant risk factor for wound dehiscence (odds ratio 1.4 [95 % confidence interval 
1.2-1.7] P<0.01). In multivariable logistic regression analysis, male gender (p=0,00) and 
COPD (p=0.03) were significant risk factors for wound dehiscence development in the acute 
surgery group. The results of the uni- and multivariable logistic regression analyses are 
presented in Table 10.21.  
 





Fig 17 Cumulative incidence of incisional hernia (Acute surgery): BMI 
 
 






Table 9 Univariable and multivariable Cox regression analyses of risk factors 
for incisional hernia 
 
 
Table 10 Univariable and multivariable logistic regression analyses of risk 
factors for wound dehiscence 
  
Cox regression analyses of risk factors for Incisional hernia.
Hazard ratio Hazard ratio
Univariate p Multivariate p
BMI>30 2.2 (1.3-3.8) 0.04 1.97 (1.1-3.5) 0.02
Wound dehiscence 3.7 (1.9-7.4) 0.00 4.8 (2.1-10.8) 0.00
Age >70 years old 0.50 (0.34-0.75) 0.001 0.65 (0.39-1.1) 0.08
Male gender 1.5 (1.0-2.2) 0,033 1.3 (0.8-2.2) 0.240
Operation time >180 min 1.4 (0.9-2.0) 0.095 1.0 (0.6-1.8) 0.733
Postoperative wound 
complication
2.3 (1.3-4.4) 0.007 1.9 (0.8-4.1) 0.12
COPD 0.80 (0.25-2.52) 0.699 0.62 (0.14-2.66) 0,52
Diabetes 2.3 (0.85-6.3) 0.103 2.9 (0.9-9.6) 0.071
Logistic regressions analysis of risk factors for Wound dehiscece
Odds ratio Odds ratio
Univariate P Multivariate P
BMI >30 1.4 (0.9-2.3) 0.18 1.58 (0.9-2.7) 0.09
Diabetes 0.70 (0.26-1.9) 0.49 0.25 (0.03-1.8) 0.17
COPD 2.16 (1.3-3.5) 0.02 2.1 (1.1-3.9) 0.03
Male gender 2.10 (1.6-2.8) 0.00 2.3 (1.6-3.5) 0.00
Age >70 years old 1.38 (1.0-1.9) 0.037 1.0 (1.00-1.04) 0.01
Operation time >180 min 1.00 (0.74-1.4) 0.99 0.72 (0.48-1.08) 0.11
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3.5 PAPER 4 
Sixteen patients were included in the study. Baseline data and outcome are presented in  
Table 11. Most of the patients underwent peritonectomy with hyperthermic intraperitoneal 
chemotherapy (HIPEC) for peritoneal metastases. Mean follow-up time in the study was 9 
months. Of the 16 patients, 1 had a seroma that needed drainage and antibiotic treatment and 
1 had a wound infection that needed antibiotic treatment. There was no complication 
requiring reoperation. No wound dehiscence or incisional hernia was seen. None of the 
participating surgeons found the onlay mesh fixation technically difficult or time-consuming. 
There were no major complaints from patients regarding discomfort related to the mesh. 
 







surgery Risk factors 
Adverse 
Events Comments  
        
1 M 42 UCC PM+AWM E+I+K -  
2 F 49 UCC PM B+E+I+K -  
3 F 58 UCC PM  A+B+C+E+I -  
4 F 65 UCC PM+AWM E+I+K -  
5 F 65 UCC PM+AWM E+F+K -  
6 F 65 UCC PM+AWM E+I+K -  
7 F 63 UCC PM+AWM E+I+K -  
8 F 55 UCC PM+AWM E+I+K -  
9 F 70 UCC PM+AWM E+I+K -  
10 F 67 UCC PM+AWM A+D+E+I+K Seroma Drain + AB 
11 F 45 UCC PM+AWM B+E+I+K -  
12 M 32 UUH Pancreatic cancer B+K -  
13 M 77 Huddinge 
Reoperation for  
dehiscence G+H+I -  






15 F 69 Huddinge 
Reoperation for 
dehiscence B+F+I+L -  
16 M 67 Huddinge 
Reoperation for 
dehiscence B+D+F -  
PM = Peritoneal Metastases, AWM = Abdominal Wall Metastases, UCC= Uppsala Cancer 
Clinic, UUH=Uppsala University Hospital AB = Antibiotic Treatment 
Risk factors: A.COPD; B.BMI > 35; C.Insulin-treated diabetes; D. Smoking; E. 
Ongoing/previous cytostatic treatment: F. Laparotomy + GI resection  < 1month previously; 
G. Reoperation; H. Acute surgery; I. Generalised cancer; J.  Albumin < 20 g/L; K. 




4.1 GENERAL COMMENTS 
Incisional hernia and wound dehiscence are midline incision complications that share the 
same pathogenesis i.e., impaired healing of the rectus aponeurosis. My clinical experience, 
which is also supported by the findings in this thesis, is that the most vulnerable patients with 
severe comorbidity develop acute wound dehiscence, whereas younger and stronger patients 
endure the postoperative period and develop an incisional hernia at a later stage. There are 
well-established methods to prevent these complications, meticulous suturing technique being 
alternative number one. In second place, prophylactic mesh augmentation may further reduce 
complications. However, for reasons of cost and time consumed, I do not think prophylactic 
mesh implantation should be standard practice but preserved for patients at high risk for 
impaired wound healing. All surgeons should be aware of these risk factors and use 
stratification tools in the preoperative workup to identify those patients likely to benefit from 
mesh reinforcement of the abdominal wall.  
This thesis studies open surgery through a midline incision, thus ignoring one important 
solution to the problem. Laparoscopic surgery has significantly lower risk for incisional 
hernia (123,124) and there is also strong evidence that fascial dehiscence is less common 
after laparoscopic surgery (125). Furthermore, laparoscopic surgery has other benefits such as 
shorter hospital stay, less need for opioid treatment etc.  














4.2 IMPLEMENTATION OF SSSB AT S:T GÖRANS HOSPITAL.   
The structured implementation of the SSSB technique in clinical practice at S:t Görans 
Hospital led to high compliance to use of the technique that remained four years later. In our 
study, 93% of midline incisions were closed using a correct SSSB technique and accurately 
registered in the surgical report. In a similar study, Tolstrup et al report 73% compliance to 
the technique (126). However, in a questionnaire study by Bloemen et al (127) where Dutch 
surgeons were asked about the technique they used for closing midline incisions, they found 
that very few followed the latest guidelines. Our conclusion is that structural implementation 
and education are essential when introducing a new surgical technique if one is to attain a 
long-lasting effect.  
No significant differences in rates of incisional hernia, wound dehiscence, or surgical site 
infection before and after introduction of SSSB for abdominal closure were found in the 
retrospective study carried out at Capio St Görans Hospital. The study found that already 
2010 – 2011 i.e., prior to introduction and implementation of SSSB, acceptable rates of 
incisional hernia and wound dehiscence existed. However, the structured implementation of 
the SSSB technique was not in vain since the use of a standardised technique enables quality 
follow-up and helps in the training of new surgeons. The SSSB technique is also a basic 





4.3 INCIDENCE OF WOUND DEHISCENCE AND INCISIONAL HERNIA.  
In the prospective randomised trials evaluating the SSSB technique, both Millburn (77) and 
Deerenberg (31) found high incidences of incisional hernia in their control arms where a 
large stitch technique was used. After implementation of the SSSB technique, the reported 
incidence was 5% and 13% respectively. Deerenberg et al used the EHS definition of 
incisional hernia where a defect seen on follow-up radiological examination, though not 
palpable, was considered a hernia. In their study, 47% of hernias were found by radiological 
examination only. This might explain the differences in incidences between these studies. 
In the retrospective studies in this thesis, the incidence of incisional hernia was around 5%. 
This suggests that the surgical techniques used by most Swedish surgeons before the SSSB 
intervention at Capio S:t Görans hospital, were satisfactory. In these studies, only clinically 
evident incisional hernias were registered. As mentioned above about 50% of insicional 
hernias are asymptomatic and only found on focused examination or radiology (29,31,37). 
Karlsson et al reported an incisional hernia rate of 25% after colorectal cancer surgery in a 
study using postoperative CT scans for diagnosis (128). In their study, 12% of patients 
needed incisional hernia surgery. When extrapolating this to the present studies, the true 
incisional hernia rate in our cohorts would be expected to be at least 10%, which is still a 
level that is generally considered acceptable in terms of patient safety. When the EHS 
definition of incisional hernia is applied (4), clinical examination underestimates the 
incidence of incisional hernia. On the other hand, results from retrospective materials such as 
ours and the study by Walming et al (75) can be seen as an estimation of the rate of clinically 
relevant incisional hernia. In which case this should be about 5% in a Swedish setting with 
acute and emergency surgery.   
Wound dehiscence is a rare complication of abdominal surgery. Kenig et al (51) and Webster 
et al (54) reported the incidence to be 2% and 3% respectively. Slater et al reported the 
incidence of wound dehiscence to be 0.4-1.2% in elective surgery and 12% in acute surgery 
(9). Tolstrup et al reported a decrease of the incidence of wound dehiscence from 7% to 4% 
after implemention of SSSB as standard technique for acute laparotomy (126). In prospective 
studies evaluating SSSB, the incidence of wound dehiscence, though not being an endpoint, 
was reported to be only 1% (31,77).  In our initial prospective follow-up at S:t Görans 
hospital, we first saw the same tendency, but in the larger retrospective follow-up we found 
an incidence of 4%. In the register study based on SCRCR data, we found a reoperation rate 
for wound dehiscence of 2,9% (2,8% after elective surgery and 4,0% after acute surgery). 
Walming et al reported an incidence of 3,3% in a comparable retrospective study (75). Since 
wound dehiscence is a rare complication, a few cases only can lead to the difference in rates 
seen between different studies. There are also large differences in inclusion criteria in studies 
published. For example, Millbourn et al excluded all patients with repeat midline incisions. A 
fair assumption is that in current clinical practice the incidence of wound dehiscence after 
elective or acute surgery should not exceed 4%. Future studies on high risk patients should 
have the 4% level as their goal.  
 
 59 
4.4 WOUND DEHISCENCE 
Wound dehiscence normally leads to long hospital stay, reoperation, intensive care treatment, 
and often several reoperations. Our register-based study showed a significantly higher 
mortality risk for after reoperation for wound dehiscence. It was shown in both our 
retrospective studies that wound dehiscence patients face a high risk for incisional hernia. 
These findings were confirmed by Jensen et al who showed that wound dehiscence patients 
have higher mortality and a high risk for developing an incisional hernia (56). To summarise, 
I believe that in a hospital aiming at high quality, every case of wound dehiscence should be 
regarded as an adverse event and that an event analysis should be performed to see if 
anything could have been done pre-, peri- or postoperatively to prevent the event.  For a 
midsize hospital such as S:t Görans Hospital with around 350 midline laparotomies per year, 
a reduction in the rate of wound dehiscence from 4% to 1% would save over one hundred 
hospital days a year and many acute operations. 
4.5  RISK FACTORS FOR INCISIONAL HERNIA AND WOUND DEHISCENCE 
In our studies, male gender, high BMI, and postoperative wound infection were found to be 
risk factors for incisional hernia and wound dehiscence.  
Chronic obstructive pulmonary disease and generalised inflammatory disease were found to 
be statistically significant risk factors for wound dehiscence.    
Age over 70 was found to be a risk factor for wound dehiscence but the risk for incisional 
hernia was lower. 
Operation time less than 180 min was found to be a risk factor for wound dehiscence, and 
long operation time an independant risk factor for incisional hernia. 
Wound dehiscence was a risk factor for incisional hernia.   
The studies in this thesis showed that male gender is a risk factor for wound complications, 
though gender as a risk factor is disputed. Contrary to our findings, a study by Seo et al 
showed that female gender was a risk factor for incisional hernia (129) and in the Swedish 
Ventral Hernia Register, 58% of patients operated for incisional hernia were female (130).  
From our studies there is strong evidence that high BMI increases the risk for incisional 
hernia and wound dehiscence. One theory is that truncal obesity, rather than high BMI itself, 
should be considered the risk factor for incisional hernia (83). Indeed, truncal obesity is more 
common in men, and may be the reason for the gender factor seen in our studies. Based on 
the findings in this thesis, I recommend considering men with a BMI>30 as having high risk 
for wound complications. I also believe that standardised measurement of perirenal fat on 
preoperative CT scans (measure of visceral obesity) combined with BMI would be a useful 




Postoperative wound infection is another risk factor for incisional hernia and wound 
dehiscence. All possible measures should be undertaken to reduce the rate of wound 
infection, the most important being correct surgical technique. In the early phase of wound 
dehiscence there is serous discharge from the wound that may be misinterpreted as a wound 
infection. This could lead to antibiotic treatment and delay in diagnosing wound dehiscence, 
and also contribute to the strong association between wound infection and wound 
dehiscence/incisional hernia.  
Postoperative surgical site infection is not a useful parameter for predicting complications. 
Furthermore, as surgical site infections are strongly associated with other wound 
complications, surgical site infection may act as confounder that obscures score-model 
assessment. Instead, future studies should focus on exploring risks associated with factors 
known preoperatively.  
High age is a well-known risk factor for wound dehiscence and has also been recognised as a 
risk factor for incisional hernia in some studies. Our studies confirm that high age is a risk 
factor for wound dehiscence, whereas lower age was a risk factor for incisional hernia. Since 
the SCRCR does not include data from the primary healthcare service, this could be a source 
of bias in this thesis. Elderly patients with a subclinical incisional hernia are likely to be 
treated conservatively under the primary healthcare system and thus overlooked. We also 
know that 50% or more of incisional hernias are asymptomatic. With increasing age and 
reduced physical activity, this rate could be even higher. It is my opinion that high age should 
be taken into consideration in the preoperative assessment since it is a well-established risk 
factor for wound dehiscence. Patients with high age and comorbidity are the ones that are at 
great risk if they develop wound dehiscence or burst abdomen, and they might not be fit for 
reoperation. Prophylactic measures such as meticulous suturing and prophylactic mesh 
augmentation can be lifesaving in these cases.  
In our studies based on SCRCR data, we found conflicting results regarding the role of 
operation time as a risk factor. That short operation time should be a risk factor for 
complication seems counter-intuitive. One explanation could be that palliative surgery and 
diagnostic surgery in critically ill patients may take less time though risk is high. A long 
operation time is a known a risk factor probably due to exhaustion of the surgeon or 
prolonged traction causing ischaemia in the abdominal wall. The patient also becomes 
exhausted and may not be fit enough for a relaparotomy. It would thus seem logical to take 
extra measures to prevent adverse events after a long operation.  
The subgroup analysis found that acute surgery increases the risk for wound dehiscence but 
does not seem to significantly increase the risk for incisional hernia. This finding is congruent 
with previous findings (55,64). Because of the increased risk for wound dehiscence, acute 





4.6 PROPHYLACTIC MESH AUGMENTATION AND TIGR® MATRIX MESH. 
Prophylactic mesh placement to prevent incisional hernia in the high-risk patient is now a 
well-established procedure (131,132). There is also evidence that prophylactic onlay mesh 
can prevent wound dehiscence (133). In our study we found that onlay placed TIGR® Matrix 
mesh is safe and is a feasible way to reinforce the midline suture. TIGR® Matrix has also 
been tested as prophylaxis after open abdomen treatment (134). There are several possible 
advantages of using absorbable mesh material, but these must be tested in future trials. 
4.7 THE SURGEON AS A RISK FACTOR.  
Garcia-Urena et al (135) discuss in their review that some surgeons regard closure of the 
abdomen as “coffee time” and assign the task to an inexperienced junior colleague. 
Sometimes there is pressure to complete the list in time, that may lead to stress at the end of 
an operation. In other cases, the surgeon may be exhausted at the end of a demanding 
operation, or perhaps the patient is not properly relaxed causing difficulty in closing the 
abdomen. All these cultural issues need to be considered by hospitals aiming at high quality. 
Closure of the abdomen is as important for the patient as the main surgery.  
All surgeons performing abdominal and pelvic surgery, not just general surgeons, need to be 
up to date on the importance of correct abdominal closure. Junior surgeons should be well 
supervised in closing the abdomen. The whole surgical organisation must be aware of the risk 
for incisional hernia so that individuals seeking to increase production consider the risk for 
complications associated with inadequate closure of the abdominal wall. Lists must be 
organised so there is time for meticulous suturing and prophylactic mesh augmentation. If the 
surgeon is exhausted, a well-rested colleague should be called in to help finish the operation. 
Good communication with the anaesthesiologist is crucial, so that the whole team 
understands the importance of abdominal wall suturing. Much suffering can be avoided and 




4.8 LIMITATIONS OF THE STUDIES 
4.8.1 Paper 1 
The intervention studied was not carried out with the aim of testing a scientific hypothesis, it 
was undertaken as a quality improvement project. As a result, there was no standardised 
follow-up protocol used in the study, instead it was performed retrospectively based on a 
review of medical records. Many patients visited the hospital only sporadically during the 
follow-up period, and patients were not examined in a strictly standard fashion. Incisional 
hernias in the study were diagnosed by either CT-scan or clinical examination during the 
follow-up period. Some of these hernias were asymptomatic. This limits comparison with 
other studies as well as the external validity of the study.  Although all patients were followed 
throughout the study period, there was possible loss to follow-up if patients left the area or 
had their incisional hernia diagnosed at another department in Stockholm. In this 
retrospective study, many important parameters could not be analysed. One such clinically 
important risk factor that could have played a crucial role was smoking, since many medical 
records lack this information. To examine the effect of the SSSB technique more accurately, 
patients should have been followed-up prospectively using a standardised protocol. Wound 
dehiscence, on the other hand, is rarely neglected, and the rate of 3.7% found accurately 
reflects wound dehiscence when SSSB is used.  
4.8.2 Paper 2 
It is well-known that approximately 50% of incisional hernias are overlooked at clinical 
examination. In the present study, 5.3% of patients were diagnosed with incisional hernia or 
underwent hernia surgery, whereas the true incidence of incisional hernia probably exceeded 
10%. Data from primary healthcare are not included in the registers used in this study, and 
there may have been patients that attended their GP with an asymptomatic incisional hernia 
that were never referred for surgical consultation. Exclusion of asymptomatic incisional 
hernias on the one hand allows focus on clinically relevant incisional hernias, but on the other 
hand prevents comparison with studies where the EHS definition of incisional hernia is 
applied (60). No association between comorbidity and risk for incisional hernia was seen. 
Patients with an incisional hernia deemed unfit for surgery could have been neglected in this 
analysis, thereby causing a selection bias. This could also explain why the rate of incisional 
hernia was higher in patients younger than 70 years. Most of the open procedures for 
colorectal cancer in this study were performed via a midline incision, but other approaches 
such as a transverse incision may have been used. The length of incision also varied and there 
was a mix of midline incisions above and below the umbilicus. These variations might bias 
the outcome of the study since they were not adjusted for. A drawback of this study is that 
there is no information about the surgical technique used to close the abdominal wall. During 
the study period 2007-2013, the implementation of SSSB gradually spread, and many 
Swedish colorectal cancer surgeons adopted the technique. The method of abdominal wall 
closure is still not included in the register, but if a similar study was repeated today, almost all 
patients would likely have their abdomen closed with the SSSB technique.  
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4.8.3 Paper 3 
Surgery for colorectal cancer is performed on a heterogeneous group of patients, and includes 
acute, elective, curative, and palliative procedures. Most procedures are performed through a 
midline incision, but there could be cases in this cohort that underwent surgery using an 
approach with a lower risk for complications, e.g. transverse incision or Pfannenstiel incision. 
As in Study 2, the length and location of the incisions varied. The surgical technique used to 
close the midline incision probably affects the risk for wound dehiscence. The modern 
technique described by Milbourn et al was introduced in Sweden during the study period, but 
no specific data on surgical technique were available in the SCRCR. This limits the external 
validity of the study. More studies on wound dehiscence are needed, and these studies should 
use the SSSB technique for abdominal wall closure.  
4.8.4 Paper 4 
The present study was too small to provide evidence of the effectiveness of the technique and 
the new mesh material. Whether or not incisional hernias develop later when the mesh is 
completely resorbed can only be determined in studies with longer follow-up times and under 
tightly controlled circumstances. The present study was a pilot study in preparation for a 
larger randomised clinical trial, the Prevmesh trial, which is described below in “Future 
perspectives”. Three surgeons from three different hospitals performed the procedures. No 
surgeon found the procedure technically difficult or time-consuming. Fig 1 used in the article 





Incisional hernia and wound dehiscence are serious and costly complications of abdominal 
surgery via a midline incision.  
The Small-Stitch-Small-Bites technique for closing the abdominal wall lowers the risk for 
incisional hernia, but despite this, 5-10% of patients will develop an incisional hernia after 
open abdominal surgery.  
Wound dehiscence is rare, but every case of wound dehiscence is a disaster for the patient. 
Wound dehiscence must be avoided at any cost.  
High age, high BMI (especially visceral obesity), long operation time, acute surgery, chronic 
obstructive pulmonary disease, systemic inflammatory disease, and male gender are risk 
factors for wound complications after a midline incision.  
Postoperative wound infection is a strong predictor of incisional hernia and wound 
dehiscence. All possible measures must be taken to avoid wound infection.  
Structured implementation of a standardised surgical technique is possible and has a long-
lasting impact on quality and outcome.  
Onlay implantation of TIGR® Matrix mesh is a feasible way to reinforce the abdominal wall 





6 FUTURE PERSPECTIVES 
In the workup leading up to this thesis, a randomised controlled trial, PrevMesh, was planned 
and launched. The aim of the trial was to test the effectiveness of a prophylactic onlay 
TIGR® Matrix mesh on the incidence of incisional hernia and wound dehiscence. The study 
population comprised patients with high risk for postoperative wound complication 
undergoing surgery through a midline incision.  The aim of the study was to include acute as 
well as planned procedures. Patients were to be randomised to two groups where the study 
group had the abdominal wall closed with the SSSB technique and reinforced with a TIGR® 
Matrix absorbable mesh. In the control group, the abdominal wall was to be closed with the 
SSSB technique but without mesh. PrevMesh was planned as a large multicentre trial 
including patients from large university hospitals to small rural hospitals. The study protocol 
is presented in Appendix 2, and more information about the study can be found at 
clinicaltrials.gov (Identifier: NCT02487134). Unfortunately, the study was paused before 
starting patient inclusion and the research question remains unanswered. Nevertheless, we 
intend to restart the study as soon as we have found sufficient funding. 
Of all the studies referred to in this thesis, very few assume that the SSSB technique was 
used. Their results might thus be considered outdated. The HULC trial (136), comparing 
standardised closure using the SSSB technique to a study group where SSSB is used and the 
suture line is reinforced with a prophylactic mesh, is therefore long awaited. The HULC trial 
will include elective surgery only and excludes many risk factors for incisional hernia.  
In future studies, patients at high risk of incisional hernia and wound dehiscence should be 
included. It may be assumed, for instance, that patients with a previous midline incision or 
previous ventral hernia repair would benefit even more from prophylactic mesh 
augmentation.  
There are promising risk calculation models for incisional hernia and wound dehiscence, and 
these should be tested in prospective trials to see if they can help reduce these adverse events.  
Another interesting field for future studies is prehabilitation. Howard et al use a standardised 
programme for patient preparation prior to surgery. In their study, patients showed a better 
physiological response to surgery and fewer complications after surgery (137). In a 
systematic review, Gillis et al concluded that nutritional prehabilitation with or without 
exercise decreases hospital stay after colorectal cancer surgery (138). Prehabilitation has also 
been tested on ventral hernia patients (139) where the prehabilitation group were less likely to 
suffer recurrence. Prehabilitation programmes prior to abdominal surgery should be the 
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9.2 APPENDIX 2 LOCAL GUIDELINES ON OPENING AND CLOSING THE 




Midline incisions are associated with severe complications such as wound dehiscence, 
wound infection, and incisional hernia. There is reliable evidence that the most effective 
way of reducing these complications is meticulous surgical technique. 
Our department has decided, without exception, to use the so-called Sundsvall technique 




• Spend time making your incision precisely in the midline. Apply the technique of 
subcutaneous fat fractioning if possible. 
• Free the aponeurosis from subcutaneous tissue 1 cm on each side before it is 
incised, in preparation for closure. 




• Measure the incision length in the relaxed position. Use a ruler. 
• Use PDS II 2-0, 150 cm, CT-1 needle.  
• Suture length/wound length quote is measured by first measuring the incision 
length. The total length of the suture used minus the lengths cut off at the ends is 
assessed. Division of the suture length by the wound length gives the ratio. 
• If the incision is longer than 30 cm you will need 2 sutures to reach a quote of at 
least 4. 
• Use self-locking start and stop knots. 
• Make sure to start at the very end of the incision. 
• Start at the end of the incision and suture continuously using small bites 5-8mm 
from the aponeurosis edges. The interval between the stitches should be less than 
5mm. 
• Take bites in the aponeurosis only. Avoid mass layered sutures. If you leave the 
midline, take bites in the anterior rectus aponeurosis only. 
• A low-tension suture is important, pull the suture so that the edges of the 
aponeurosis just adapt. The assistant should hold the suture without increasing the 
tension. The suture must be visible but the distance between the edges should be 
<10mm  
• Suture length/wound length must be greater than 4, and the ratio must be measured 
and noted in the operation notes. 
• If a ratio of four is not achieved, the suture must be redone. The ratio has no 
maximum.  
• The theatre nurse has the responsibility to reach the surgeon a pair of scissors if a 
ratio of 4 is not achieved. If the surgeon choses to deviate from this routine, a non-
compliance report must be made stating the reasons why. 
• The skin must be closed with intracutaneous Monocryl® suture. If this is not 
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1. DOCUMENT REVISION HISTORY 
Edition Date Changes 
1 2015-01-15 Initial version 
2 2017-09-01 Changes include: 
Overall: New arrangement and administrative changes of the study protocol 
New title: PrevMesh -a randomised study to compare routine abdominal wall closure with 
reinforcement using TIGR Matrix surgical mesh in the onlay position.  
5) Primary and secondary objectives: the objectives explained in more detail. 
7) Study Procedures: clarified that the randomisation will be performed using randomisation 
envelopes instead of electronic randomisation, changed eCRF system. Updated text on the 
blinding procedure. 
9) Clinical assessments: follow-up visit at 3 years instead of 2 years. 
10) Discontinuation criteria: new section that includes information that the patients are free to 
discontinue their participation in the study at any time, and that the patient can also be 
withdrawn from the study if medically necessary. 
11)Data management: changed eCRF system and included more clarification about password 
etc. 
12) Sample size estimation: 200 enrolled patients instead of the 400 in the initial protocol 
version. 
14.1) Patient information and informed consent: more detailed information added. 
14.3) Monitoring: since a monitor will perform site visits to monitor the eCRF data, this is 
clarified in the updated text. 
14.4) Data protection and patience insurance: additional clarification 
14.4) Suspension and early termination: new section 
15) Investigator responsibilities: responsibilities clarified in more detail. 
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3. PROTOCOL SYNOPSIS 
 
Rationale: Wound dehiscence and incisional hernias are common complications after major surgery. A wound dehiscence, 
i.e., rupture of the wound along the stitches in the fascia, may turn into complete dehiscence if the skin sutures also rupture 
and the abdominal contents protrude through the wall. Wound dehiscence can be lethal, especially in the elderly. It can 
lead to bowel lesions, infections, and organ failure. The risk of repeated wound dehiscence is also increased once 
dehiscence has occurred. The rationale of this study is to confirm patient benefit using a reinforcing surgical mesh in 
patients undergoing abdominal surgery. 
Inclusion Criteria: 
• patients undergoing abdominal surgery 
• 2 risk factors (See Section 5.2.3 below) 
• Wound length >10 cm 
• Signed informed consent 
• Age ≥18 years 
 
Exclusion Criteria:  
• Presence of mesh after previous surgery 
• Presence of incisional hernia 
• Wound length <10 cm 
• Pregnancy 
• Age < 18 years 
• Infected wounds 
Primary Objective: 
o To compare incisional hernia rates one year after surgery between the standard treatment group and 
reinforcing surgical mesh group. 
 
o To compare wound dehiscence rates one year after surgery between the standard treatment group and 
reinforcing surgical mesh group 
Secondary Objectives: 
o To compare cumulative incisional hernia incidence three years and five years after surgery between the 
standard treatment group and reinforcing surgical mesh group. 
o To determine whether placing TIGR matrix surgical mesh in the onlay position is safe in routine clinical 
practice. 
o To compare seroma rates within one year and infection rates within one month after surgery, between the 
standard treatment group and reinforcing surgical mesh group 
o To compare numbers of patients with discomfort and/or persisting pain between the standard treatment 
group and reinforcing surgical mesh group after 30-days,one, three and five years. 
o To evaluate whether a resorbable TIGR.matrix mesh applied onlay reduces the risk for burst abdomen. 
o To perform a Health Economics evaluation to estimate the costs related to incisional hernia and burst 
abdomen (including a cost benefit estimation of placing a prophylactic resorbable mesh at laparotomy). 
o To describe the health-related quality-of-life status after laparotomy with and without placing a 
prophylactic mesh. 
Study Design: Multicentre, parallel-group, randomised study on patients undergoing laparotomy. 
Number of patients and sites: 
There will be 200 patients enrolled in the study, 100 patients in each group. Estimated number of participating sites:  4-10 
 
Duration of the study: The study will begin August 2017, patient enrolment will carry on until Dec 2018. The study is 
scheduled to end Dec 2023.  
4. INTRODUCTION 
Wound dehiscence and incisional hernias are common? complications after major surgery. A 
wound dehiscence, i.e., rupture of the wound along the stitches in the fascia, may turn into 
complete dehiscence if the skin sutures also rupture and the abdominal contents protrude through 
the abdominal wall. Wound dehiscence can be lethal, especially in the elderly. It may lead to bowel 
lesions, infections, and organ failure. The risk for repeated wound dehiscence is also increased 
once a dehiscence has occurred. 
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Whereas a wound dehiscence develops during the initial healing phase, an incisional hernia occurs 
after the primary healing phase i.e., after new peritoneum has developed. Due to incomplete 
healing, weakening of the abdominal wall may persist, leading to protrusion of the peritoneum and 
its contents. An incisional hernia may cause severe local symptoms and limit the ability to perform 
daily activities. If an incisional hernia incarcerates, it may become life-threatening. Techniques to 
repair incisional hernias do exist, but these repairs are very costly. Furthermore, an incisional 
hernia repair may lead to chronic pain and the functional results are seldom as favourable as after 
primary closure without hernia development. 
Despite the fact the main risk factors for wound dehiscence have been identified and the technique 
for closing the abdominal wall has improved in recent years, the incidence of wound dehiscence 
after colorectal surgery is still 5-10 %. The measurable costs, including the costs for reoperation, 
prolonged hospital stay, and costs for other interventions are very high1. Measures to prevent 
wound dehiscence will be very cost-effective, reducing healthcare costs and improving health-
related quality-of-life. 
A way to prevent incisional hernias and wound dehiscence is to place a prophylactic mesh in the 
onlay position. This has been shown to radically decrease the risk for incisional hernia 2-4. In a 
previous randomised study, it was shown that fixating a polypropylene mesh on the aponeurosis 
with 3 cm overlap on either side reduced the rate of incisional hernia within one year from more 
than 30% to less than 2 %3. There are, however, problems with leaving a mesh permanently in 
place, including seroma, infections, and persistent pain. A way to avoid this would be to reinforce 
the closure using a resorbable mesh so that any problems related to the mesh will eventually cease 
as the mesh is resorbed. 
TIGR Matrix surgical mesh is a completely synthetic slowly resorbable mesh. It is knitted from 
two different synthetic resorbable fibres, possessing different degradation characteristics. The first 
fibre, making up 40% of the matrix by weight, is a copolymer of polyglycolide, polylactide, and 
polytrimethylene carbonate. The second fibre, making up 60% of the matrix by weight, is a 
copolymer of polylactide, and polytrimethylene carbonate. Both fibres degrade by bulk hydrolysis 
once implanted, resulting in a decreasing strength retention followed by mass loss of the fibres. 
In a pilot study at three units in Sweden, TIGR Matrix surgical mesh was placed in the onlay 
position following procedures where the risk for postoperative burst abdomen or incisional hernia 
was considered to be high. The only mesh-related complication requiring treatment was a seroma 
in one patient, which was managed conservatively. 
This investigation is a randomised controlled study to assess whether TIGR Matrix surgical mesh 
in the onlay position reduces the risk for burst abdomen and incisional hernia. Routine wound 
closure will be compared to the same routines but adding onlay TIGR Matrix surgical mesh.  
5. STUDY OBJECTIVES 
 
6. Primary Objectives 
o To compare incisional hernia rates one year after surgery between the standard 
treatment group and reinforcing surgical mesh group. 
 
o To compare wound dehiscence rates one year after surgery, between the standard 




7. Secondary Objectives 
o To compare incisional hernia rates three and five years after surgery between the 
standard treatment group and reinforcing surgical mesh group. 
o To determine whether placing TIGR matrix surgical mesh in the onlay position is 
safe in routine clinical practice. 
o To compare the incidence of seroma within one year and infections within one 
month after surgery 
o To compare the numbers of patients with discomfort and/or persistent pain between 
the standard treatment group and reinforcing surgical mesh group after 30-days,one, 
three, and five years. 
o To evaluate whether onlay resorbable TIGR matrix surgical mesh reduces the risk 
forburst abdomen. 
o To perform a Health Economics evaluation to estimate the costs related to 
incisional hernias and burst abdomen (including a cost benefit estimation of placing 
a prophylactic resorbable mesh at laparotomy). 
o To describe the health-related quality-of-life status after laparotomy with and 
without placing a prophylactic mesh. 
 
8. STUDY DESIGN 
A randomised, multicentre study aimed to compare the risk for incisional hernia and burst 
abdomen between patients who undergo prophylactic reinforcement of the aponeurosis with onlay 
TIGR matrix surgical mesh and patients undergoing wound closure according to established 
routines. 
 
9. Selection of Study population 
Patients planned for elective surgery via a midline incision for colon or rectal cancer will be screened 
for this study. Included are: 
o Patients undergoing emergency surgery? with an abdominal midline incision for 
peritonitis, intestinal obstruction and other diagnoses. 
o Patients planned to undergo other types of abdominal incision? (transverse incision, 
subcostal incision, large T-type incisions (“Mercedes incision”) or a large incision 
combined with midline and transverse divisions of the abdominal wall.  
 
10. Inclusion and Exclusion Criteria 
The inclusion and exclusion criteria for enrolling patients in this clinical investigation are the 
following: 
11. Inclusion Criteria 
 
▪ patients undergoing abdominal surgery 
▪ 2 risk factors (See Section 5.2.3 below) 
▪ Wound length >10 cm 
▪ Signed informed consent 
 




▪ Presence of mesh after previous surgery 
▪ Presence of incisional hernia 
▪ Wound length <10 cm 
▪ Pregnancy 
▪ Age < 18 years 
▪ Infected wounds 
 
13. Risk factors for wound dehiscence and incisional hernia 
▪ Reoperation 
▪ Age over 80 years 
▪ Generalised malignant decease (presence of distant metastases at the time 
of surgery) 
▪ COPD (Chronic obstructive pulmonary disease). Grades III-IV according 
to the GOLD classification (FEV1 < 50% of the expected) 
▪ Serum Albumin level <20 g/l 
▪ Sepsis. Infection in combination with two or more of the following: 
abnormal body temperature, heart rate, respiratory rate or blood gas, and 
white blood cell count. 
▪ BMI 35-45 (for patients with BMI>45, no additional risk factors are 
required for inclusion) 
▪ Haemoglobin <80 g/l 
▪ Diabetes with secondary complications (angiopathy, nephropathy, or 
neuropathy) and insulin treatment 
▪ Steroid treatment (with at least 1 mg betamethasone daily or equivalent) for 
7 days preoperatively 
▪ Smoking (at least 10 cigarettes a day for one year) 
▪ Chemotherapy (last administration within 2 weeks prior to surgery 
▪ Radiation to the abdominal wall 
 
14. STUDY PROCEDURES 
 
15. Randomisation procedure 
Patients who fulfil the inclusion criteria with none of the exclusion criteria are invited to participate in 
the study prior to surgery.  
The Investigator will be responsible for the verbal and written patient information and for 
obtaining informed consent from each patient. The screening section in the eCRF will be 
completed, if worksheets are used instead, the eCRF must be filled in later. The randomisation 
procedure will be carried out after closure of the fascia, by opening a randomisation envelope 
(located in the site master file). The envelope contains a note stating whether patient is 
randomised to wound closure of the abdominal wall according to ordinary routine with fascial 
sutures, or closure with fascial sutures according to ordinary routine plus the addition of TIGR matrix 
surgical mesh applied onlay. An independent biostatistician not involved in other aspects of the 
study will be responsible for the preparation of randomisation envelopes. 
Postoperative management is the same in both groups and adapted to local routines and the 
specific procedure the patient has undergone. Since postoperative complications related to the 
mesh may occur, there will be no blinding of the investigators and study staff, but patients should not 




16. Wound closure 
In cases where the patient is randomised to the TIGR Matrix surgical mesh group and antibiotics have 
not been given for any other indication, peroperative 1.5 g Cefuroxim intravenously (iv) will be given 
peroperatively as prophylaxis. In cases where the patient does not tolerate Cefuroxim, 600 mg 
Clindamycin iv will be given instead. Prophylactic antibiotics given will be registered. The same 
principles for wound closure will be applied in both groups5. The aponeurosis will be closed with 
continuous PDS 2/0 sutures and self-locking anchor knots. The stitches will be placed 5-8 mm from 
the wound edge, 4-5 mm apart. The suture to wound length ratio will be recorded. 
If the patient is randomised to placement of TIGR Matrix surgical mesh, the subcutaneous tissue will 
be dissected from the aponeurosis 4 cm on either side of the incision as well as in cranial and caudal 
directions. A TIGR matrix surgical mesh 7 cm wide and 6 cm longer than the incision will be placed 
onlay and fixated with continuous PDS 2/0 stitches to the aponeurosis on either side of the incision. 
The stitches fixating the aponeurosis should be placed with an interval of 10 mm. 
The time required to close the abdomen, including closing the midline incision and, if 
applicable, placement of the mesh, will be registered. 
 







22. INVESTIGATION PRODUCT (IP) 
TIGR® Matrix Surgical Mesh is a CE-marked medical mesh knitted from two different synthetic resorbable fibres 
possessing different degradation properties. The first fibre, making up 40% of the matrix by weight, is a copolymer of 
polyglycolide, polylactide, and polytrimethylene carbonate. The second fibre, making up 60% of the matrix by weight, 
is a copolymer of polylactide, and polytrimethylene carbonate. Both fibres degrade by bulk hydrolysis once 
implanted, resulting in a decreasing strength retention followed by mass loss of the fibres. Based on the product’s 
absorption characteristics, in vitro testing showed that the first fibre (polyglycolide, polylactide, and 
polytrimethylene carbonate) loses its functional capabilities after 2 weeks and in vivo studies in the abdominal wall 





1 month 1 year 3 years 5 years 
Inclusion Criteria X      
Exclusion Criteria X      
Informed Consent X      
Follow-up outpatient visit    X X X X 
CRF Completion X X X X X X 
Fill in RAND-36   X X X X 
Ventral Hernia Pain 
Questionnaire6  
  X X X X 
Adverse Event Assessment  X X X X X 
Computer tomography    X   
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second fibre (polylactide, and polytrimethylene carbonate) loses its functional capabilities after 9 months and in 
vivo studies in the abdominal wall of sheep indicated that the second fibre should be absorbed after approximately 
36 months. TIGR Matrix Surgical Mesh, is a resorbable mesh implant, classified as a Class III device in accordance 
with the European Medical Device Directive (MDD) 93/42/EEC, Annex IX, Section 2.4, Rule 8.  
 
23. CLINIAL ASSESSMENTS 
24. Screening/Baseline assessment 
The following variables are registered in the eCRF: 
• Birth Year 
• Gender 
• Length (cm) 
• Weight (kg) 
• BMI  
• Inclusion/Exclusion criteria fulfilled 
• Medical history and concurrent diseases  
• Prior and concomitant medication/treatment  
• Physical examination   
• Preoperative risk factors ( 2 risk factors essential) 
• Indication for surgery including ICD-code 
• Incision and suture length, and length ratio  
• Time from start of fascia closure to end of mesh suture 




26. Follow-up assessments 
A clinical follow-up visit will be made at 30-days, one year, three years, and five years after 
surgery. At the follow-up visits, all patients will be monitored for signs of infection, wound 
rupture, incisional hernia, subcutaneous seroma, and postoperative symptoms. Other adverse events 
related to the IP and serious adverse device effects (SADE) will be registered as well as any 
serious complications that could be related to the presence of the mesh. Patients will also be 
requested to fill in RAND-36 (Appendix A) and the item worst pain last week from the Ventral 
Hernia Pain Questionnaire6 (Appendix B). A computer scan one year after surgery will also be 
included in the follow-up schedule. 
The patients are not allowed to participate concurrently in any other clinical investigation 
concerning abdominal wall closure.  
If more than three serious complications related to the mesh are registered, a data safety 
committee will determine if the study should be interrupted or not. 
 
27. DISCONTINUATION CRITERIA 
 
Patients are free to discontinue participation in the clinical investigation at any time. A patient 
can also be withdrawn from the clinical investigation if, in the opinion of the investigator, it is 
medically necessary. If isolated visits are not attended, this is not a reason to withdraw the 
patient. If a patient does not return for a scheduled follow-up visit, the investigator will make 
reasonable efforts to contact the patient. Whatever, every effort should be made to document 
patient outcome. For patients who are withdrawn, the date of withdrawal from the clinical 
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investigation and the reason for withdrawal will be recorded in the eCRF (e.g. lost to follow-
up, consent withdrawn, protocol violation, SADEs etc). All evaluations scheduled for the final 
clinical investigation visit should be completed as soon as possible after the patient is 
withdrawn from the clinical investigation. Withdrawn patients should not be re-entered into the 
clinical investigation. 
28. DATA MANAGEMENT 
Data management based on Good Clinical Practice (GCP) refers to the activities defined to 
achieve safe routines for entering patient information into a database, avoiding errors. 
The data management routines include procedures for handling of e-CRF, database set-up and 
management, data entry and verification, data validation, quality control (QC) of database, and 
documentation of the performed activities including information of discrepancies in the process. 
The database, data entry screens, and programme will be designed in accordance with the Study 
Protocol by Scandinavian CRO. 
Clinical data will be entered into an eCRF. The eCRF includes password protection and internal 
quality checks, such as automatic range checks, to identify data that appear inconsistent, 
incomplete, or inaccurate.  
The site investigator must verify that all data entries in the eCRF are accurate and correct. This 
is done with an investigator signature for each patient’s CRF data set. Sites will also be 
monitored, see section 12.3. The eCRF used in this study will be “Trial on-line”. 
29. SAMPLE SIZE ESTIMATION 
 
Patients with at least two risk factors are expected to have a risk of at least 10 % to develop an 
incisional hernia after one year if no prophylactic mesh is used7. If a prophylactic mesh reduces this 
risk to 1.5% one year after surgery, 90 patients in each group with complete data are required to 
achieve an 80% chance of detecting a difference at the p<0.05 level. To compensate for 10 % 
dropout and death before end of follow-up, the goal is to include a total of 100 patients in each 
group. 
 
Estimated number of participating sites: 4-10 
 
30. STATISTICS PLAN  
Statistical study analyses will be performed after the study is completed and the database is released. 
All statistics, including tables, figures, and listings, will be performed using SAS®, version 9.2 or 
higher. The statistical analyses will be described in detail in the Statistical Analysis Plan (SAP) 
which will be finalised and approved before database lock.  
 
31. Descriptive Statistics 
All data will be presented using descriptive statistics. Results will be presented in total and by 
treatment group. Continuous variables will be summarised using number of patients, mean, standard 
deviation, median, minimum and maximum. Categorical variables will be summarised using the 
number and percentage of patients. The full analysis set is defined as all randomised patients who 




33. Primary Endpoints 
• incisional hernia one year after surgery 
• wound dehiscence one year after surgery  
 
34. Secondary Endpoints 
• incisional hernia three years and five years after surgery 
• incidence of seroma within one year  
• infections within one month after surgery 
• wound dehiscence 1 months after surgery  
• RAND-36 
• VHPQ 
35. ADMINISTRATIVE AND REGULATORY REQUIREMENTS 
36.  
37. Patient Information and Informed Consent 
Inclusion in the study requires oral and written consent. It is the responsibility of the Site 
Investigator to give each patient adequate verbal and written information regarding the objectives 
and the procedures of the study as well as any risks or inconvenience involved before including the 
patient in the study. The patient should be informed that by signing the informed consent form, 
he/she authorises monitor(s), auditor(s), and the EC to have direct access to their medical records 
for verification of clinical study procedures. The patient must be informed about the right to 
withdraw from the study at any time. The patient should be allowed sufficient time for 
consideration of the proposal.  
 
In signing the consent form, the patient or his/her legal representative shall 
− agree to participate in and comply with the clinical investigation, 
− agree to his/her personal physician being informed of his/her participation, or state his/her 
refusal to release of this information, 
− agree to the use of his/her relevant personal data for the purpose of the clinical 
investigation. 
 
The signed informed consent forms must be filed by the Site Investigator for possible future audits 
and/or inspections. The final version of the patient information and informed consent forms will be 
submitted to the EC and must not be changed without permission from the Sponsor.  
38.  
39. Approval from Ethics Committee and the Radiation Safety Authority 
Approval from the Ethics Committee (EC) will be obtained. Any substantial amendment(s) that 
arise(s) during the study will be submitted for approval to the same EC. Furthermore, as patients 






The Site Investigator at each unit is responsible for assuring that the principles of GCP are followed. 
However, monitoring visits to each investigational site will be conducted by the assigned monitor as 
described in the monitoring plan. The investigator will allow the monitor to inspect the clinical 
facilities to assure compliance with GCP. The CRFs and patient’s corresponding original medical 
records (source documents) are to be fully available for review by the monitor at regular intervals.  
These reviews verify adherence to study protocol and data accuracy in accordance with federal 
regulations and local regulations. A monitor from Scandinavian CRO (SCRO) will carry out all 
monitoring activities. 
 
42. Data Protection and Patience Insurance  
For data protection purposes, the sponsor and the Site Investigators will ensure the confidentiality of 
the data of the study participants. Personuppgiftsansvarig for this study is Karolinska 
Universitetssjukhuset. 
 
The patients will be informed that their personal identity information will be replaced by a code 
“subject study number”. The investigator will keep a link (ID-log) that identifies a patient to 
his/hers coded information, but this link will be kept secure and available only to the investigator or 
selected members of the research team (this list should be preserved for monitoring and/or possible 
future inspections/audits). 
 
Any information that can identify a patient will remain confidential. Any personal 
information that could identify a patient will be removed or changed before files are shared 
with other researchers or results are made public. The Swedish regulations for the handling 
of computerised data will be followed throughout the study.  
43. Suspension or early termination of the clinical investigation 
If an investigation is terminated prematurely or suspended, the sponsor shall promptly 
inform the clinical investigators/investigation centres of the termination or suspension and 
the reason(s) for this.  
The Ethics Committee shall also be informed promptly and provided with the reason(s) for 
the termination or suspension by the sponsor or by the clinical investigator/investigation 
centres. 
44. INVESTIGATOR RESPONSIBILITIES 
 
The clinical investigator shall be responsible for the day-to-day conduct of the clinical investigation 
as well as for the safety and well-being of the human patients involved in the clinical investigation. 
The clinical investigator shall: 
• make sure that the study protocol is followed by all responsible for the conduct of the 
clinical trial 
• ensure that the patient has adequate information to give informed consent 
• ensure that informed consent is obtained and documented 
• have primary responsibility for the accuracy, legibility, and security of all clinical 
investigation data, documents and patient records at his investigation site both during and 
after the clinical investigation. 
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• support the monitor and auditor, if applicable, in their activities to verify compliance with 
the study protocol, to perform source data verification and to correct the CRF where 
inconsistencies or missing values are identified. 
45. QUALITY ASSURANCE 
The study will be conducted in accordance with GCP. All study procedures will be 
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47. APPENDIX A RAND-36 Questionnaire 
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Patient will assess worst perceived pain the past week according to a VHPQ item. The 
following question will be asked “Gradera smärtan i magen då den var som värst under 
senaste veckan?” 
 Ingen smärta 
 Smärta som lätt har kunnat ignoreras 
 Smärta som inte har kunnat ignoreras, men som inte påverkat dina 
vardagsaktiviteter 
 Smärta som inte har kunnat ignoreras, och som påverkat koncentrationen på 
sysslor/aktiviteter 
 Smärta som har förhindrat de flesta aktiviteter 
 Smärta som har krävt vila/sängläge 
 Smärta som har varit så svår att du var tvungen att söka omedelbar hjälp 
 
 
 
 
